1
|
Haghighatdoost F, Mehrabani-Zeinabad K, Hajihashemi P, Mohammadifard N, Adibi P. Burden of colorectal cancer and its risk factors in the North Africa and Middle East (NAME) region, 1990-2019: a systematic analysis of the global burden of disease study. BMC Public Health 2024; 24:557. [PMID: 38388875 PMCID: PMC10882825 DOI: 10.1186/s12889-024-18027-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/27/2023] [Accepted: 02/07/2024] [Indexed: 02/24/2024] Open
Abstract
OBJECTIVE The geographical differences in incidence rates of colorectal cancer (CRC) and its burden due to modifiable risk factors warrant investigating the CRC burden and its risk factors in different regions. In the current study, we aimed to estimate the burden of CRC and the share of its risk factors in the North Africa and Middle East (NAME), from 1990 to 2019. STUDY DESIGN Systematic review. METHODS The rates of incidence, prevalence, death, years of life lost (YLL), years lived with disability (YLD), and disability adjusted life years (DALYs) of CRC were estimated through the framework of the Global Burden of Diseases (GBD), Injuries and Risk Factors Study 2019 by age, sex, between 1990 and 2019. The CRC-related DALYs attributable to each lifestyle and metabolic risk factor was also estimated through a comparative risk assessment approach. RESULTS In NAME region, the trends of incidence, prevalence, death, YLL, YLD, and DALYs of CRC were increasing, with higher rates in males than females over this period. High and high-middle socio-demographic index (SDI) countries had greater CRC DALYs rate compared with middle- and low-SDI countries in 2019, except for Palestine [434.66 (95% UI: 368.82, 503.88)]. In NAME region, like the global, dietary risk (33.18%), low whole grain intake (19.79%), and low intake of milk (15.77%) were the major contributing risk factors to DALYs due to CRC in 2019. CONCLUSIONS Due to increasing trend of CRC burden and the considerable role of lifestyle and metabolic factors in its burden in NAME region, implementing fundamental strategies to minimize CRC burden and its risk factors is imperative.
Collapse
Affiliation(s)
- Fahimeh Haghighatdoost
- Isfahan Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
| | - Kamran Mehrabani-Zeinabad
- Isfahan Gastroenterology and Hepatology Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
| | - Parisa Hajihashemi
- Isfahan Gastroenterology and Hepatology Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
| | - Noushin Mohammadifard
- Isfahan Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
| | - Peyman Adibi
- Isfahan Gastroenterology and Hepatology Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
| |
Collapse
|
2
|
Sharma R, Abbastabar H, Abdulah DM, Abidi H, Abolhassani H, Abrehdari-Tafreshi Z, Absalan A, Ali HA, Abu-Gharbieh E, Acuna JM, Adib N, Sakilah Adnani QE, Aghaei A, Ahmad A, Ahmad S, Ahmadi A, Ahmadi S, Ahmed LA, Ajami M, Al Hamad H, Al Hasan SM, Alanezi FM, Saeed Al-Gheethi AA, Al-Hanawi MK, Ali A, Ali BA, Alimohamadi Y, Aljunid SM, Ali Al-Maweri SA, Alqahatni SA, AlQudah M, Al-Raddadi RM, Al-Tammemi AB, Ansari-Moghaddam A, Anwar SL, Anwer R, Aqeel M, Arabloo J, Arab-Zozani M, Ariffin H, Artaman A, Arulappan J, Ashraf T, Askari E, Athar M, Wahbi Atout MM, Azadnajafabad S, Badar M, Badiye AD, Baghcheghi N, Bagherieh S, Bai R, Bajbouj K, Baliga S, Bardhan M, Bashiri A, Baskaran P, Basu S, Belgaumi UI, Nazer C Bermudez A, Bhandari B, Bhardwaj N, Bhat AN, Bitaraf S, Boloor A, Hashemi MB, Butt ZA, Chadwick J, Kai Chan JS, Chattu VK, Chaturvedi P, Cho WC, Darwesh AM, Dash NR, Dehghan A, Dhali A, Dianatinasab M, Dibas M, Dixit A, Dixit SG, Dorostkar F, Dsouza HL, Elbarazi I, Elemam NM, El-Huneidi W, Elkord E, Abdou Elmeligy OA, Emamian MH, Erkhembayar R, Ezzeddini R, Fadoo Z, Faiz R, Fakhradiyev IR, Fallahzadeh A, Faris MEM, Farrokhpour H, Fatehizadeh A, Fattahi H, Fekadu G, Fukumoto T, Gaidhane AM, Galehdar N, Garg P, Ghadirian F, Ghafourifard M, Ghasemi M, Nour MG, Ghassemi F, Gholamalizadeh M, Gholamian A, Ghotbi E, Golechha M, Goleij P, Goyal S, Mohialdeen Gubari MI, Gunasekera DS, Gunawardane DA, Gupta S, Habibzadeh P, Haeri Boroojeni HS, Halboub ES, Hamadeh RR, Hamoudi R, Harorani M, Hasanian M, Hassan TS, Hay SI, Heidari M, Heidari-Foroozan M, Hessami K, Hezam K, Hiraike Y, Holla R, Hoseini M, Hossain MM, Hossain S, Hsieh VCR, Huang J, Hussein NR, Hwang BF, Iravanpour F, Ismail NE, Iwagami M, Merin J L, Jadidi-Niaragh F, Jafarinia M, Jahani MA, Jahrami H, Jaiswal A, Jakovljevic M, Jalili M, Jamshidi E, Jayarajah U, Jayaram S, Jha SS, Jokar M, Joseph N, Kabir A, Kabir MA, Kadir DH, Kakodkar PV, Kalankesh LR, Kalankesh LR, Kalhor R, Kaliyadan F, Kamal VK, Kamal Z, Kamath A, Kar SS, Karimi H, Kaur N, Keikavoosi-Arani L, Keykhaei M, Khader YS, Khajuria H, Khan EA, Khan MN, Khan M, Khan MA, Khan YH, Khanmohammadi S, Khatatbeh MM, Khateri S, Khayamzadeh M, Khayat Kashani HR, Kim MS, Kompani F, Koohestani HR, Koulmane Laxminarayana SL, Krishan K, Kumar N, Kumar N, Kutluk T, Kuttikkattu A, Ching Lai DT, Lal DK, Lami FH, Lasrado S, Lee SW, Lee SW, Lee YY, Lee YH, Leong E, Li MC, Liu J, Madadizadeh F, Mafi AR, Mahjoub S, Malekzadeh R, Malik AA, Malik I, Mallhi TH, Mansournia MA, Martini S, Mathews E, Mathur MR, Meena JK, Menezes RG, Mirfakhraie R, Mirinezhad SK, Mirza-Aghazadeh-Attari M, Mithra P, Mohamadkhani A, Mohammadi S, Mohammadzadeh M, Mohan S, Mokdad AH, Al Montasir A, Montazeri F, Moradi M, Sarabi MM, Moradpour F, Moradzadeh M, Moraga P, Mosapour A, Motaghinejad M, Mubarik S, Muhammad JS, Murray CJ, Nagarajan AJ, Naghavi M, Nargus S, Natto ZS, Nayak BP, Nejadghaderi SA, Nguyen PT, Niazi RK, Noroozi N, Okati-Aliabad H, Okekunle AP, Ong S, Oommen AM, Padubidri JR, Pandey A, Park EK, Park S, Pati S, Patil S, Paudel R, Paudel U, Pirestani M, Podder I, Pourali G, Pourjafar M, Pourshams A, Syed ZQ, Radhakrishnan RA, Radhakrishnan V, Rahman M, Rahmani S, Rahmanian V, Ramesh PS, Rana J, Rao IR, Rao SJ, Rashedi S, Rashidi MM, Rezaei N, Rezaei N, Rezaei N, Rezaei S, Rezaeian M, Roshandel G, Chandan S, Saber-Ayad MM, Sabour S, Sabzmakan L, Saddik B, Saeed U, Safi SZ, Sharif-Askari FS, Sahebkar A, Sahoo H, Sajedi SA, Sajid MR, Salehi MA, Farrokhi AS, Sarasmita MA, Sargazi S, Sarode GS, Sarode SC, Sathian B, Satpathy M, Semwal P, Senthilkumaran S, Sepanlou SG, Shafeghat M, Shahabi S, Shahbandi A, Shahraki-Sanavi F, Shaikh MA, Shannawaz M, Sheikhi RA, Shobeiri P, Shorofi SA, Shrestha S, Siabani S, Singh G, Singh P, Singh S, Sinha DN, Siwal SS, Sreeram S, Suleman M, Abdulkader RS, Sultan I, Sultana A, Tabish M, Tabuchi T, Taheri M, Talaat IM, Tehrani-Banihashemi A, Temsah MH, Thangaraju P, Thomas N, Thomas NK, Tiyuri A, Tobe-Gai R, Toghroli R, Tovani-Palone MR, Ullah S, Unnikrishnan B, Upadhyay E, Tahbaz SV, Valizadeh R, Varthya SB, Waheed Y, Wang S, Wickramasinghe DP, Wickramasinghe ND, Xiao H, Yonemoto N, Younis MZ, Yu C, Zahir M, Zaki N, Zamanian M, Zhang ZJ, Zhao H, Zitoun OA, Zoladl M. Temporal patterns of cancer burden in Asia, 1990-2019: a systematic examination for the Global Burden of Disease 2019 study. Lancet Reg Health Southeast Asia 2024; 21:100333. [PMID: 38361599 PMCID: PMC10866992 DOI: 10.1016/j.lansea.2023.100333] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 05/04/2023] [Revised: 11/08/2023] [Accepted: 11/15/2023] [Indexed: 02/17/2024]
Abstract
Background Cancers represent a challenging public health threat in Asia. This study examines the temporal patterns of incidence, mortality, disability and risk factors of 29 cancers in Asia in the last three decades. Methods The age, sex and year-wise estimates of incidence, mortality, and disability-adjusted life years (DALYs) of 29 cancers for 49 Asian countries from 1990 through 2019 were generated as a part of the Global Burden of Disease, Injuries and Risk Factors 2019 study. Besides incidence, mortality and DALYs, we also examined the cancer burden measured in terms of DALYs and deaths attributable to risk factors, which had evidence of causation with different cancers. The development status of countries was measured using the socio-demographic index. Decomposition analysis was performed to gauge the change in cancer incidence between 1990 and 2019 due to population growth, aging and age-specific incidence rates. Findings All cancers combined claimed an estimated 5.6 million [95% uncertainty interval, 5.1-6.0 million] lives in Asia with 9.4 million [8.6-10.2 million] incident cases and 144.7 million [132.7-156.5 million] DALYs in 2019. The age-standardized incidence rate (ASIR) of all cancers combined in Asia was 197.6/100,000 [181.0-214.4] in 2019, varying from 99.2/100,000 [76.1-126.0] in Bangladesh to 330.5/100,000 [298.5-365.8] in Cyprus. The age-standardized mortality rate (ASMR) was 120.6/100,000 [110.1-130.7] in 2019, varying 4-folds across countries from 71.0/100,000 [59.9-83.5] in Kuwait to 284.2/100,000 [229.2-352.3] in Mongolia. The age-standardized DALYs rate was 2970.5/100,000 [2722.6-3206.5] in 2019, varying from 1578.0/100,000 [1341.2-1847.0] in Kuwait to 6574.4/100,000 [5141.7-8333.0] in Mongolia. Between 1990 and 2019, deaths due to 17 of the 29 cancers either doubled or more, and 20 of the 29 cancers underwent an increase of 150% or more in terms of new cases. Tracheal, bronchus, and lung cancer (both sexes), breast cancer (among females), colon and rectum cancer (both sexes), stomach cancer (both sexes) and prostate cancer (among males) were among top-5 cancers in most Asian countries in terms of ASIR and ASMR in 2019 and cancers of liver, stomach, hodgkin lymphoma and esophageal cancer posted the most significant decreases in age-standardized rates between 1990 and 2019. Among the modifiable risk factors, smoking, alcohol use, ambient particulate matter (PM) pollution and unsafe sex remained the dominant risk factors between 1990 and 2019. Cancer DALYs due to ambient PM pollution, high body mass index and fasting plasma glucose has increased most notably between 1990 and 2019. Interpretation With growing incidence, cancer has become more significant public health threat in Asia, demanding urgent policy attention and guidance. Its heightened risk calls for increased cancer awareness, preventive measures, affordable early-stage detection, and cost-effective therapeutics in Asia. The current study can serve as a useful resource for policymakers and researchers in Asia for devising interventions for cancer management and control. Funding The GBD study is funded by the Bill and Melinda Gates Foundation.
Collapse
|
3
|
Ou Z, Li X, Cui J, Zhu S, Feng K, Ma J, Wu K, Chen Y, Su Y, Tang S, Duan D, Ren Y, Zhang X, Liang J, Wang Z. Global, regional, and national burden of asbestosis from 1990 to 2019 and the implications for prevention and control. Sci Total Environ 2023; 904:166346. [PMID: 37591378 DOI: 10.1016/j.scitotenv.2023.166346] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/31/2023] [Revised: 08/11/2023] [Accepted: 08/14/2023] [Indexed: 08/19/2023]
Abstract
BACKGROUND Asbestosis is a common pneumoconiosis caused by long-term asbestos exposure. Analysis of the burden of asbestosis would help in creating informed public health strategies. METHODS Data on asbestosis were analyzed using the Global Burden of Disease study 2019. The estimated annual percentage change (EAPC) was calculated to demonstrate temporal trends in the age-standardized rate (ASR) of asbestosis from 1990 to 2019. RESULTS Globally, 36,339 incident cases of asbestosis, led to 3572 deaths and 71,225 disability adjusted life years (DALYs) in 2019. During 1990-2019, the overall ASRs of incidence and DALYs declined by an annual average of 0.29 % and 0.27 %, with the respective EAPCs being -0.29 (95 % confidence interval [CI]: -0.43, -0.14) and -0.27 (95%CI: -0.53, -0.01). The ASRs of mortality increased with EAPC of 0.65 (95%CI: 0.34, 0.96). Trends in incidence and prevalence rose in females, but declined in males. The asbestosis burden was heterogeneous across regions and countries. The heaviest burden of asbestosis was observed in the United States, India, and China. Trends in ASRs of asbestosis varied across countries/territories. Pronounced increasing trends in incidence and prevalence occurred in Georgia, Iran, and Croatia. CONCLUSIONS Decreasing incident trend of asbestosis was observed globally over the past three decades. However, the ongoing asbestosis burden highlighted that asbestosis remained a challenge to public health, and cost-effective measures were required to reduce the asbestosis burden.
Collapse
Affiliation(s)
- Zejin Ou
- Key Laboratory of Occupational Environment and Health, Guangzhou Twelfth People's Hospital, Guangzhou, China
| | - Xin Li
- School of Basic Medicine and Public Health, Jinan University, Guangzhou, China
| | - Jiaxin Cui
- School of Public Health, Sun Yat-Sen University, Guangzhou, China
| | - Shaofang Zhu
- Key Laboratory of Occupational Environment and Health, Guangzhou Twelfth People's Hospital, Guangzhou, China
| | - Kexin Feng
- Key Laboratory of Occupational Environment and Health, Guangzhou Twelfth People's Hospital, Guangzhou, China
| | - Jialao Ma
- School of Public Health, Guangzhou Medical University, Guangzhou, China
| | - Kangyong Wu
- School of Public Health, Guangzhou Medical University, Guangzhou, China
| | - Yuquan Chen
- Key Laboratory of Occupational Environment and Health, Guangzhou Twelfth People's Hospital, Guangzhou, China
| | - Yiwei Su
- Key Laboratory of Occupational Environment and Health, Guangzhou Twelfth People's Hospital, Guangzhou, China
| | - Shihao Tang
- Key Laboratory of Occupational Environment and Health, Guangzhou Twelfth People's Hospital, Guangzhou, China
| | - Danping Duan
- Key Laboratory of Occupational Environment and Health, Guangzhou Twelfth People's Hospital, Guangzhou, China
| | - Yixian Ren
- Key Laboratory of Occupational Environment and Health, Guangzhou Twelfth People's Hospital, Guangzhou, China
| | - Xing Zhang
- Institute of Occupational Diseases, Hangzhou Medical College (Zhejiang Academy of Medical Sciences), Hangzhou, China
| | - Jiabin Liang
- Key Laboratory of Occupational Environment and Health, Guangzhou Twelfth People's Hospital, Guangzhou, China
| | - Zhi Wang
- Key Laboratory of Occupational Environment and Health, Guangzhou Twelfth People's Hospital, Guangzhou, China.
| |
Collapse
|
4
|
Sharma R. Temporal patterns of breast cancer incidence, mortality, disability-adjusted life years and risk factors in 12 South American Countries, 1990-2019: an examination using estimates from the global burden of disease 2019 study. Breast Cancer Res Treat 2023; 202:529-540. [PMID: 37717225 DOI: 10.1007/s10549-023-07075-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/25/2023] [Accepted: 08/06/2023] [Indexed: 09/19/2023]
Abstract
BACKGROUND AND AIM Breast cancer (BC) is one of the leading causes of cancer deaths in females in South America. This study aims to examine the BC burden in 12 South American countries between 1990 and 2019. DATA AND METHODS The estimates of BC burden and risk factors were procured from the Global Burden of Disease 2019 study for the period 1990-2019. Development levels of countries were gauged using socio-demographic index (SDI). Decomposition analysis was employed to categorize the change in incidence between 1990 and 2019 into three factors: population growth, population aging and age-specific incidence rate. Estimated annual percent changes were calculated for each country and bivariate association between country-level age-standardized rates and SDI was examined using pooled regression. RESULTS The age-standardized rates of breast cancer were the highest in Uruguay [incidence: 72.65 per 100,000 (55.79-92.57); mortality: 29.97 per 100,000 (27.54-32.27); disability-adjusted life years (DALYs: 810.49 per 100,000 (746.22-884.55)] and lowest in Peru [incidence: 27.63 per 100,000 (20.44-36.85); mortality: 10.79 per 100,000 (8.14-14.11); DALYs: 318.27 per 100,000 (234.47-421.16)]. Mortality-to-incidence ratio (MIR) across countries varied from 0.30 in Colombia to 0.55 in Bolivia in 2019. SDI had a positive and strong association with age-standardized incidence rate [Formula: see text] and weaker positive association with age-standardized mortality rate [Formula: see text] and age-standardized DALYs rate [Formula: see text]. Most countries experienced more than 70% increase in incident cases owing to population aging and age-specific incidence rates. Alcohol Use, diet high in red meat and smoking contributed the maximum DALYs in most countries in 2019 whereas DALYs due to high body-mass index and high fasting plasma glucose increased most substantially between 1990 and 2019. CONCLUSION With increasing incidence, high MIR and rising BC burden due to modifiable risk factors, several public health interventions are required in South America focusing on prevention, BC awareness among general public, cost-effective early detection and treatments that suit the socio-economic setup of South American countries.
Collapse
Affiliation(s)
- Rajesh Sharma
- Humanties and Social Sciences, National Institute of Technology Kurukshetra, Kurukshetra, India.
| |
Collapse
|
5
|
Li S, Tuerxunyiming M, Sun Z, Zheng SY, Liu QB, Zhao Q. Burden of diabetes attributable to dietary cadmium exposure in adolescents and adults in China. Environ Sci Pollut Res Int 2023; 30:102353-102362. [PMID: 37667123 PMCID: PMC10567932 DOI: 10.1007/s11356-023-29424-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/24/2023] [Accepted: 08/17/2023] [Indexed: 09/06/2023]
Abstract
At present, the health risk assessment of cadmium exposure has become a major focus of environmental health research. However, there is still a lack of systematic research on the burden of diabetes (DM) attributable to dietary cadmium exposure in adolescents and adults in China. Using the top-down method, the blood cadmium level (B-Cd) of Chinese adolescents and adults from 2001 to 2023 was combined with the relative risk (RR) of cadmium-induced diabetes to calculate the population attribution score (PAF). Subsequently, PAF was used to assess the disease burden (DB) of diabetes caused by cadmium exposure, expressed in disability adjusted life years (DALYs), and attribution analysis was carried out for cadmium exposure from different sources. The average blood cadmium concentration in Chinese adolescents and adults was 1.54 ± 1.13 µg/L, and the burden of DM attributable to cadmium exposure was 56.52 (44.81, 70.33) × 105 DALYs. The contribution rate of dietary cadmium exposure was 59.78%, and the burden of DM attributable to dietary cadmium exposure was 337.86 (267.85, 420.42) × 108 DALYs. In addition, the highest blood cadmium concentrations were found in Henan, Shanxi, and Jiangxi provinces, while the highest burden of DM attributable to cadmium exposure was found in Jiangsu, Henan, and Guangdong provinces. Cadmium exposure is a risk factor for DM, and we need to take comprehensive action to reduce the burden of DM attributable to dietary cadmium from health, economic, and social perspectives.
Collapse
Affiliation(s)
- Shan Li
- Department of Preventive Medicine, Medical College, Shihezi University, Shihezi, 832002, China
| | - Muhadasi Tuerxunyiming
- School of Medicine, Hangzhou City University, Hangzhou, 310015, Zhejiang Province, China
| | - Zhe Sun
- Department of Endocrinology, The First Hospital of Qiqihar, The Affiliated Qiqihar Hospital of Southern Medical University, Qiqihar, 161005, Heilongjiang, China
| | - Su-Yang Zheng
- Department of Orthopaedics, Nanjing First Hospital, Nanjing Medical University, Nanjing, 210006, China
| | - Qing-Bai Liu
- Department of Orthopaedics, Nanjing First Hospital, Nanjing Medical University, Nanjing, 210006, China
| | - Qing Zhao
- Department of Endocrinology, Lianshui People's Hospital of Kangda College Affiliated to Nanjing Medical University, Huai'an, 223400, Jiangsu Province, China.
| |
Collapse
|
6
|
Guzman-Esquivel J, Murillo-Zamora E, Ortiz-Mesina M, Galvan-Salazar HR, De-Leon-Zaragoza L, Casarez-Price JC, Delgado-Enciso J, Delgado-Enciso I. Regional and national burden of prostate cancer: incidence, mortality, years of life lost, and disability-adjusted life years, in Mexico and Latin America from 1990 to 2019. Int Urol Nephrol 2023; 55:2155-2160. [PMID: 37273013 PMCID: PMC10240458 DOI: 10.1007/s11255-023-03653-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/24/2023] [Accepted: 05/27/2023] [Indexed: 06/06/2023]
Abstract
PURPOSE Prostate cancer (PC) is the second leading cause of cancer and the fifth cause of cancer-related death. This manuscript aims to determine the incidence, mortality, and Disability Adjusted Life Years (DALYs) trends of PC in the last 30 years in Latin America and Mexico. METHODS We performed a cross-sectional analysis of a publicly available data set. Data regarding the burden of prostate cancer in 20 Latin-American countries, and the 32 states of Mexico, were retrieved from the Global Burden of Disease Study 2019. Collected information included incidence and mortality rates (per 100,000), as well as the DALYs as absolute numbers and rates (per 100,000) and the annual rates of change in rates from 1990 to 2019. RESULTS In Latin America in males aged 55 years or older, the mean incidence rate was 344 cases per 100,000. The number of deaths attributable to prostate cancer observed was 67,110 and the mean mortality rate was 210 per 100,000. The overall burden of disease was 1,120,709 DALYs and the contribution of years of life lost (YLL) was 91.7% ([Formula: see text] = 1,027,946). Mexico presented an incidence rate (279.6) and mortality (99.1) rate (per /100 thousand). In Mexico, 13 states had a DALYs' rate above the national mean (883 per 100,000) and the highest burden (1360 DALYs/100,000) were documented in the state of Guerrero (Southwestern Mexico). CONCLUSION Only two Latin-American countries (Brazil and Colombia) and eight states of Mexico showed a decreased trend about the rate of change of DALYs in the last 30 years.
Collapse
Affiliation(s)
- Jose Guzman-Esquivel
- Clinical Epidemiology Research Unit, Mexican Social Security Institute, Av. Lapislazuli No. 250, El Haya, 28984, Villa de Álvarez, Colima, Mexico
| | - Efren Murillo-Zamora
- Clinical Epidemiology Research Unit, Mexican Social Security Institute, Av. Lapislazuli No. 250, El Haya, 28984, Villa de Álvarez, Colima, Mexico
| | - Monica Ortiz-Mesina
- Headquarters of Medical Services, Mexican Social Security Institute, Doroteo López 442, Col. Magisterial, Colima, Mexico
| | - Hector R Galvan-Salazar
- Clinical Laboratory, Mexican Social Security Institute. HGZ1, Av. Lapislazuli No. 250, El Haya, 28984, Villa de Álvarez, Colima, Mexico
| | - Luis De-Leon-Zaragoza
- Department of Research, Cancerology State Institute, Colima State Health Services, Liceo de Varones 401, La Esperanza, 28085, Colima, Colima, Mexico
| | - Juan C Casarez-Price
- Department of Research, Cancerology State Institute, Colima State Health Services, Liceo de Varones 401, La Esperanza, 28085, Colima, Colima, Mexico
| | - Josuel Delgado-Enciso
- Foundation for Ethics Education and Cancer Research of the IEC of Colima AC, Av. Liceo de Varones 401 Colonia la Esperanza, 28085, Colima, Mexico
| | - Ivan Delgado-Enciso
- Department of Research, Cancerology State Institute, Colima State Health Services, Liceo de Varones 401, La Esperanza, 28085, Colima, Colima, Mexico.
- Molecular Biology Laboratory, School of Medicine, University of Colima, Av. Universidad 333, colonia la Esperanza, 28040, Colima, Mexico.
| |
Collapse
|
7
|
Deng P, Fu Y, Chen M, Wang D, Si L. Temporal trends in inequalities of the burden of cardiovascular disease across 186 countries and territories. Int J Equity Health 2023; 22:164. [PMID: 37620895 PMCID: PMC10463977 DOI: 10.1186/s12939-023-01988-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/03/2023] [Accepted: 08/14/2023] [Indexed: 08/26/2023] Open
Abstract
BACKGROUND Cardiovascular disease (CVD) is a leading cause of morbidity and mortality globally. The extent to which CVD affects the population's health varies across countries. Moreover, quantitative estimates of the trend of inequalities in CVD burden remain unclear. The objective of our study was to assess the socioeconomic inequalities and temporal trends of CVD burden across 186 countries and territories from 2000 to 2019. METHODS We extracted data from the Global Burden of Disease, Injuries, and Risk Factors Study (GBD) 2019, and conducted a cross-national time-series analysis. Age-standardized disability-adjusted life-year (DALY) rates were used to measure the burden of CVDs, and gross national income (GNI) per capita was used to approximate the socioeconomic development. Concentration curves and concentration indexes (CIs) were generated to evaluate the cross-national socioeconomic inequality of CVD burden. A joinpoint regression analysis was used to quantify the changes in trends in socioeconomic inequality of CVD burden from 2000 to 2019. RESULTS The age-standardized DALY rates of CVDs decreased in 170 (91%) of 186 countries from 2000 to 2019. The concentration curves of the age-standardized DALY rates of CVDs were above the equality line from 2000 to 2019, indicating a disproportional distribution of CVD burden in low-income countries. The CIs declined from - 0.091 (95% CI: -0.128 to - 0.054) in 2000 to - 0.151 (95% CI: -0.190 to - 0.112) in 2019, indicating worsened pro-poor inequality distributions of CVD burden worldwide. A four-phase trend of changes in the CIs of age-standardized DALY rates for CVD was observed from 2000 to 2019, with an average annual percentage change (AAPC) of - 2.7% (95% CI: -3.0 to - 2.4). Decreasing trends in CIs were observed in all CVD subcategories but endocarditis, with AAPC ranging from - 6.6% (95% CI: -7.3 to - 5.9) for ischemic heart disease to - 0.2% (95% CI: -0.4 to - 0.1) for hypertensive heart disease. CONCLUSIONS Globally, the burden of CVD has decreased in more than 90% of countries over the past two decades, accompanied by an increasing trend of cross-country inequalities. Moreover, the overall burden of CVD continues to fall primarily on low-income countries.
Collapse
Affiliation(s)
- Penghong Deng
- School of Health Policy & Management, Nanjing Medical University, Nanjing, China
| | - Yu Fu
- Nanjing Drum Tower Hospital, Nanjing, China
| | - Mingsheng Chen
- School of Health Policy & Management, Nanjing Medical University, Nanjing, China
- Center for Global Health, Nanjing Medical University, Nanjing, China
| | - Dong Wang
- School of Public Administration, Nanjing University of Finance and Economics, Qixia District, Nanjing, 210023, China.
| | - Lei Si
- School of Health Sciences, Western Sydney University, Campbelltown, NSW, Australia
- Translational Health Research Institute, Western Sydney University, Penrith, NSW, Australia
| |
Collapse
|
8
|
Lin P, Lee PI, Ling MP. Probabilistic benefit-risk analysis of fish: Nutritional benefit versus methylmercury-contaminated risk. Mar Pollut Bull 2023; 193:115179. [PMID: 37352805 DOI: 10.1016/j.marpolbul.2023.115179] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/23/2023] [Revised: 06/08/2023] [Accepted: 06/12/2023] [Indexed: 06/25/2023]
Abstract
This paper carries out probabilistic approach to quantify the benefit-risk analysis for foods (BRAFO) of omega-3 polyunsaturated fatty acid and methylmercury (MeHg) for the people who eat the mercury-contaminated fish in Taiwan. We applied the hazard quotient (HQ) model to assess the risk of developmental neuropsychological impairment effect and the desirable dose index (DI) model to quantify the health benefits. Besides, we also applied the disability adjusted life years (DALY) model to assess the number of years lost by incidence of affected infants' intelligence quotient (IQ) and coronary heart disease (CHD) or Stroke for adult. The results of this study show that although the risk of cod and scad are higher, Taiwan residents do not need to reduce intake rate based on benefit considerations. Furthermore, according to the benefits of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), this study suggests that more intake of saury and salmon.
Collapse
Affiliation(s)
- Pinpin Lin
- National Institute of Environmental Health Sciences, National Health Research Institutes, Zhunan, Miaoli County, Taiwan
| | - Pei-I Lee
- Institute of Food Safety and Risk Assessment, National Taiwan Ocean University, Keelung City, Taiwan
| | - Min-Pei Ling
- Department of Food Science, National Taiwan Ocean University, Keelung City, Taiwan.
| |
Collapse
|
9
|
Sharma R, Rakshit B. Spatial and temporal patterns of colorectal cancer in Asia, 1990-2019. Int J Clin Oncol 2023; 28:255-67. [PMID: 36520255 DOI: 10.1007/s10147-022-02274-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/28/2022] [Accepted: 11/07/2022] [Indexed: 12/23/2022]
Abstract
BACKGROUND Asia accounts for the largest burden of colorectal cancer (CRC) worldwide. This study examines the temporal patterns of CRC in Asia in the last three decades. METHODS The data pertaining to CRC burden measured by incidence, mortality, and disability-adjusted-life-years (DALYs) and its risk factors for 49 countries in the Asian continent were drawn from the Global Burden of Disease 2019 study between 1990 and 2019. Mortality-to-incidence ratio (MIR) was employed as a proxy indicator of 5-year survival rates. RESULTS In Asia, incident cases more than tripled from 270,851 to 1.1 million, deaths tripled from 183,252 to 560,426, and DALYs more than doubled from 5 million to 13.4 million between 1990 and 2019. The age-standardized incidence rate (ASIR) increased from 14.0/100,000 to 23.9/100,000, age-standardized mortality rate (ASMR) increased from 10.1/100,000 to 12.5/100,000, and MIR decreased from 0.68 to 0.50 between 1990 and 2019. ASIR varied 10-folds across countries from 5.6/100,000 in Bangladesh to 62.0/100,000 in Taiwan in 2019 and ASMR from 4.9/1000 in Bangladesh to 30.3/100,000 in Brunei. In 2019, diet low in milk (18.7%) and whole grains (15.2%) and calcium (16.6%) were the major contributory risk factors in CRC DALYs in 2019. CONCLUSION CRC is a fast-rising neoplasm in Asia and its burden can be curtailed by focusing on primary prevention (e.g., diet and physical activity) and secondary prevention through screening. The policy focus and resources must be directed towards capacity building, including cancer infrastructure and quality data availability from cancer registries.
Collapse
|
10
|
Haagsma JA, Charalampous P, Ariani F, Gallay A, Moesgaard Iburg K, Nena E, Ngwa CH, Rommel A, Zelviene A, Abegaz KH, Al Hamad H, Albano L, Liliana Andrei C, Andrei T, Antonazzo IC, Aremu O, Arumugam A, Atreya A, Aujayeb A, Ayuso-Mateos JL, Engelbert Bain L, Banach M, Winfried Bärnighausen T, Barone-Adesi F, Beghi M, Bennett DA, Bhagavathula AS, Carvalho F, Castelpietra G, Caterina L, Chandan JS, Couto RAS, Cruz-Martins N, Damiani G, Dastiridou A, Demetriades AK, Dias-da-Silva D, Francis Fagbamigbe A, Fereshtehnejad SM, Fernandes E, Ferrara P, Fischer F, Fra.Paleo U, Ghirini S, Glasbey JC, Glavan IR, Gomes NGM, Grivna M, Harlianto NI, Haro JM, Hasan MT, Hostiuc S, Iavicoli I, Ilic MD, Ilic IM, Jakovljevic M, Jonas JB, Jerzy Jozwiak J, Jürisson M, Kauppila JH, Kayode GA, Khan MAB, Kisa A, Kisa S, Koyanagi A, Kumar M, Kurmi OP, La-Vecchia C, Lamnisos D, Lasrado S, Lauriola P, Linn S, Loureiro JA, Lunevicius R, Madureira-Carvalho A, Mechili EA, Majeed A, Menezes RG, Mentis AFA, Meretoja A, Mestrovic T, Miazgowski T, Miazgowski B, Mirica A, Molokhia M, Mohammed S, Monasta L, Mulita F, David Naimzada M, Negoi I, Neupane S, Oancea B, Orru H, Otoiu A, Otstavnov N, Otstavnov SS, Padron-Monedero A, Panda-Jonas S, Pardhan S, Patel J, Pedersini P, Pinheiro M, Rakovac I, Rao CR, Rawaf S, Rawaf DL, Rodrigues V, Ronfani L, Sagoe D, Sanmarchi F, Santric-Milicevic MM, Sathian B, Sheikh A, Shiri R, Shivalli S, Dora Sigfusdottir I, Sigurvinsdottir R, Yurievich Skryabin V, Aleksandrovna Skryabina A, Smarandache CG, Socea B, Sousa RARC, Steiropoulos P, Tabarés-Seisdedos R, Roberto Tovani-Palone M, Tozija F, Van de Velde S, Juhani Vasankari T, Veroux M, Violante FS, Vlassov V, Wang Y, Yadollahpour A, Yaya S, Sergeevich Zastrozhin M, Zastrozhina A, Polinder S, Majdan M. The burden of injury in Central, Eastern, and Western European sub-region: a systematic analysis from the Global Burden of Disease 2019 Study. Arch Public Health 2022; 80:142. [PMID: 35590340 PMCID: PMC9121595 DOI: 10.1186/s13690-022-00891-6] [Citation(s) in RCA: 9] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/27/2022] [Accepted: 05/02/2022] [Indexed: 01/13/2023] Open
Abstract
BACKGROUND Injury remains a major concern to public health in the European region. Previous iterations of the Global Burden of Disease (GBD) study showed wide variation in injury death and disability adjusted life year (DALY) rates across Europe, indicating injury inequality gaps between sub-regions and countries. The objectives of this study were to: 1) compare GBD 2019 estimates on injury mortality and DALYs across European sub-regions and countries by cause-of-injury category and sex; 2) examine changes in injury DALY rates over a 20 year-period by cause-of-injury category, sub-region and country; and 3) assess inequalities in injury mortality and DALY rates across the countries. METHODS We performed a secondary database descriptive study using the GBD 2019 results on injuries in 44 European countries from 2000 to 2019. Inequality in DALY rates between these countries was assessed by calculating the DALY rate ratio between the highest-ranking country and lowest-ranking country in each year. RESULTS In 2019, in Eastern Europe 80 [95% uncertainty interval (UI): 71 to 89] people per 100,000 died from injuries; twice as high compared to Central Europe (38 injury deaths per 100,000; 95% UI 34 to 42) and three times as high compared to Western Europe (27 injury deaths per 100,000; 95%UI 25 to 28). The injury DALY rates showed less pronounced differences between Eastern (5129 DALYs per 100,000; 95% UI: 4547 to 5864), Central (2940 DALYs per 100,000; 95% UI: 2452 to 3546) and Western Europe (1782 DALYs per 100,000; 95% UI: 1523 to 2115). Injury DALY rate was lowest in Italy (1489 DALYs per 100,000) and highest in Ukraine (5553 DALYs per 100,000). The difference in injury DALY rates by country was larger for males compared to females. The DALY rate ratio was highest in 2005, with DALY rate in the lowest-ranking country (Russian Federation) 6.0 times higher compared to the highest-ranking country (Malta). After 2005, the DALY rate ratio between the lowest- and the highest-ranking country gradually decreased to 3.7 in 2019. CONCLUSIONS Injury mortality and DALY rates were highest in Eastern Europe and lowest in Western Europe, although differences in injury DALY rates declined rapidly, particularly in the past decade. The injury DALY rate ratio of highest- and lowest-ranking country declined from 2005 onwards, indicating declining inequalities in injuries between European countries.
Collapse
Affiliation(s)
- Juanita A. Haagsma
- grid.5645.2000000040459992XDepartment of Public Health, Erasmus MC, University Medical Center, Rotterdam, The Netherlands
| | - Periklis Charalampous
- grid.5645.2000000040459992XDepartment of Public Health, Erasmus MC, University Medical Center, Rotterdam, The Netherlands
| | - Filippo Ariani
- Epidemiology Unit, Central Tuscany Local Health Authority, Florence, Italy
| | - Anne Gallay
- grid.493975.50000 0004 5948 8741Department of Non-Communicable Diseases and Injuries, Santé Publique France, Saint-Maurice, France
| | - Kim Moesgaard Iburg
- grid.7048.b0000 0001 1956 2722Department of Public Health, Aarhus University, Aarhus, Denmark
| | - Evangelia Nena
- grid.12284.3d0000 0001 2170 8022Laboratory of Social Medicine, Medical School, Democritus University of Thrace, Alexandroupolis, Greece
| | - Che Henry Ngwa
- grid.8761.80000 0000 9919 9582School of Public Health and Community Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden ,grid.22903.3a0000 0004 1936 9801Department of Epidemiology and Population Health, Faculty of Health Sciences, American University of Beirut, Beirut, Lebanon
| | - Alexander Rommel
- grid.13652.330000 0001 0940 3744Department of Epidemiology and Health Monitoring, Robert Koch Institute, Berlin, Germany
| | - Ausra Zelviene
- Institute of Hygiene, Health Information Center, Kaunas, Lithuania
| | - Kedir Hussein Abegaz
- grid.412132.70000 0004 0596 0713Department of Biostatistics, Near East University, Nicosia, Cyprus ,Department of Biostatistics and Health Informatics, Madda Walabu University, Bale Robe, Ethiopia
| | - Hanadi Al Hamad
- grid.413548.f0000 0004 0571 546XGeriatrics and Long Term Care Department, Hamad Medical Corporation, Doha, Qatar
| | - Luciana Albano
- grid.9841.40000 0001 2200 8888Department of Experimental Medicine, University of Campania Luigi Vanvitelli, Naples, Italy
| | - Catalina Liliana Andrei
- grid.8194.40000 0000 9828 7548Cardiology Department, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania
| | - Tudorel Andrei
- grid.432032.40000 0004 0416 9364Department of Statistics and Econometrics, Bucharest University of Economic Studies, Bucharest, Romania
| | - Ippazio Cosimo Antonazzo
- grid.7563.70000 0001 2174 1754Research Center On Public Health, University of Milan-Bicocca, Monza, Italy
| | - Olatunde Aremu
- grid.19822.300000 0001 2180 2449Department of Public Health, Birmingham City University, Birmingham, UK
| | - Ashokan Arumugam
- grid.412789.10000 0004 4686 5317Department of Physiotherapy, College of Health Sciences, University of Sharjah, Sharjah, United Arab Emirates
| | - Alok Atreya
- grid.429382.60000 0001 0680 7778Department of Forensic Medicine, Lumbini Medical College, Palpa, Nepal
| | - Avinash Aujayeb
- grid.451090.90000 0001 0642 1330Northumbria Healthcare NHS Foundation Trust, Cramlington, UK
| | - Jose Luis Ayuso-Mateos
- grid.411251.20000 0004 1767 647XHospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-Princesa), Madrid, Spain ,grid.413448.e0000 0000 9314 1427Carlos III Health Institute, Biomedical Research Networking Center for Mental Health Network (CiberSAM), Madrid, Spain
| | - Luchuo Engelbert Bain
- grid.36511.300000 0004 0420 4262Lincoln International Institute for Rural Health (LIIRH), University of Lincoln, Lincoln, UK ,Global South Health Services and Research, GSHS, Amsterdam, The Netherlands
| | - Maciej Banach
- grid.8267.b0000 0001 2165 3025Department of Hypertension, Medical University of Lodz, Lodz, Poland ,grid.415071.60000 0004 0575 4012Polish Mothers’ Memorial Hospital Research Institute, Lodz, Poland
| | - Till Winfried Bärnighausen
- grid.7700.00000 0001 2190 4373Heidelberg Institute of Global Health (HIGH), Heidelberg University, Heidelberg, Germany ,grid.38142.3c000000041936754XT.H. Chan School of Public Health, Harvard University, Boston, MA USA
| | - Francesco Barone-Adesi
- grid.16563.370000000121663741Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy
| | | | - Derrick A. Bennett
- grid.4991.50000 0004 1936 8948Clinical Trials Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK
| | - Akshaya S. Bhagavathula
- grid.43519.3a0000 0001 2193 6666Institute of Public Health, United Arab Emirates University, Al Ain, United Arab Emirates ,grid.4491.80000 0004 1937 116XDepartment of Social and Clinical Pharmacy, Charles University, Hradec Kralova, Prague, Czech Republic
| | - Félix Carvalho
- grid.5808.50000 0001 1503 7226Research Unit On Applied Molecular Biosciences (UCIBIO), University of Porto, Porto, Portugal
| | - Giulio Castelpietra
- Outpatient and Inpatient Care Service, Central Health Directorate, Friuli Venezia Giulia Region, Trieste, Italy
| | - Ledda Caterina
- grid.8158.40000 0004 1757 1969Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy
| | - Joht Singh Chandan
- grid.6572.60000 0004 1936 7486Institute of Applied Health Research, University of Birmingham, Birmingham, UK
| | - Rosa A. S. Couto
- grid.5808.50000 0001 1503 7226Department of Chemical Sciences, University of Porto, Porto, Portugal
| | - Natália Cruz-Martins
- grid.5808.50000 0001 1503 7226Faculty of Medicine, University of Porto, Porto, Portugal ,grid.5808.50000 0001 1503 7226Institute for Research & Innovation in Health (i3S), University of Porto, Porto, Portugal ,Institute of Research and Advanced, Training in Health Sciences and Technologies (INFACTS), Gandra, Portugal
| | - Giovanni Damiani
- grid.4708.b0000 0004 1757 2822Clinical Dermatology, IRCCS Istituto Ortopedico Galeazzi, University of Milan, Milan, Italy ,grid.67105.350000 0001 2164 3847Department of Dermatology, Case Western Reserve University, Cleveland, OH USA
| | - Anna Dastiridou
- grid.411299.6Department of Ophthalmology, University Hospital of Larissa, Larissa, Greece
| | - Andreas K. Demetriades
- grid.418716.d0000 0001 0709 1919Edinburgh Spinal Surgery Outcome Studies Group, Department of Neurosurgery, Royal Infirmary of Edinburgh, Edinburgh, UK
| | - Diana Dias-da-Silva
- grid.5808.50000 0001 1503 7226Laboratory of Toxicology, Faculty of Pharmacy, University of Porto, Porto, Portugal
| | - Adeniyi Francis Fagbamigbe
- grid.9582.60000 0004 1794 5983Department of Epidemiology and Medical Statistics, Faculty of Public Health, College of Medicine, University of Ibadan, Ibadan, Nigeria
| | - Seyed-Mohammad Fereshtehnejad
- grid.28046.380000 0001 2182 2255Division of Neurology, Department of Medicine, University of Ottawa, Ottawa, ON Canada ,grid.4714.60000 0004 1937 0626Division of Clinical Geriatrics, Department of Neurobiology, Karolinska Institute, Stockholm, Sweden
| | - Eduarda Fernandes
- grid.5808.50000 0001 1503 7226Associated Laboratory for Green Chemistry (LAQV), University of Porto, Porto, Portugal
| | - Pietro Ferrara
- grid.7563.70000 0001 2174 1754Research Center On Public Health, University of Milan-Bicocca, Monza, Italy
| | - Florian Fischer
- grid.6363.00000 0001 2218 4662Institute of Public Health, Charité-Universitätsmedizin Berlin, Berlin, Germany
| | - Urbano Fra.Paleo
- grid.8393.10000000119412521Research Institute for Sustainable Land Development (Interra), University of Extremadura, Caceres, Spain
| | - Silvia Ghirini
- grid.416651.10000 0000 9120 6856National Center On Addictions and Doping, Istituto Superiore Di Sanità, Rome, Italy
| | - James C. Glasbey
- grid.6572.60000 0004 1936 7486NIHR Global Health Research Unit On Global Surgery, University of Birmingham, Birmingham, UK
| | - Ionela-Roxana Glavan
- grid.432032.40000 0004 0416 9364Department of Statistics and Econometrics, Bucharest University of Economic Studies, Bucharest, Romania
| | - Nelson G. M. Gomes
- grid.5808.50000 0001 1503 7226Associated Laboratory for Green Chemistry (LAQV), University of Porto, Porto, Portugal ,grid.5808.50000 0001 1503 7226Department of Chemistry, University of Porto, Porto, Portugal
| | - Michal Grivna
- grid.43519.3a0000 0001 2193 6666Institute of Public Health, United Arab Emirates University, Al Ain, United Arab Emirates
| | - Netanja I. Harlianto
- grid.7692.a0000000090126352Department of Orthopedics, University Medical Center Utrecht, Utrecht, Netherlands
| | - Josep Maria Haro
- Biomedical Research Networking Center for Mental Health Network (CiberSAM), Madrid, Spain ,Research and Development Unit, San Juan de Dios Sanitary Park, Sant Boi de Llobregat, Spain
| | - M. Tasdik Hasan
- grid.414142.60000 0004 0600 7174International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh ,grid.10025.360000 0004 1936 8470Department of Primary Care and Mental Health, University of Liverpool, Liverpool, UK
| | - Sorin Hostiuc
- grid.8194.40000 0000 9828 7548Department of Legal Medicine and Bioethics, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania ,Clinical Legal Medicine Department, National Institute of Legal Medicine Mina Minovici, Bucharest, Romania
| | - Ivo Iavicoli
- grid.4691.a0000 0001 0790 385XDepartment of Public Health, University of Naples Federico II, Naples, Italy
| | - Milena D. Ilic
- grid.413004.20000 0000 8615 0106Department of Epidemiology, University of Kragujevac, Kragujevac, Serbia
| | - Irena M. Ilic
- grid.7149.b0000 0001 2166 9385Faculty of Medicine, University of Belgrade, Belgrade, Serbia
| | - Mihajlo Jakovljevic
- grid.448878.f0000 0001 2288 8774N. A. Semashko Department of Public Health and Healthcare, I. M. Sechenov First Moscow State Medical University, Moscow, Russia ,grid.413004.20000 0000 8615 0106Department of Global Health, Economics and Policy, University of Kragujevac, Kragujevac, Serbia
| | - Jost B. Jonas
- grid.7700.00000 0001 2190 4373Department of Ophthalmology, Heidelberg University, Mannheim, Germany ,grid.414373.60000 0004 1758 1243Beijing Institute of Ophthalmology, Beijing Tongren Hospital, Beijing, China
| | - Jacek Jerzy Jozwiak
- grid.107891.60000 0001 1010 7301Department of Family Medicine and Public Health, University of Opole, Opole, Poland
| | - Mikk Jürisson
- grid.10939.320000 0001 0943 7661Institute of Family Medicine and Public Health, University of Tartu, Tartu, Estonia
| | - Joonas H. Kauppila
- grid.4714.60000 0004 1937 0626Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden ,grid.10858.340000 0001 0941 4873Surgery Research Unit, University of Oulu, Oulu, Finland
| | - Gbenga A. Kayode
- grid.421160.0International Research Center of Excellence, Institute of Human Virology Nigeria, Abuja, Nigeria ,grid.5477.10000000120346234Julius Centre for Health Sciences and Primary Care, Utrecht University, Utrecht, The Netherlands
| | - Moien A. B. Khan
- grid.43519.3a0000 0001 2193 6666Department of Family Medicine, United Arab Emirates University, Al-Ain, United Arab Emirates ,grid.451052.70000 0004 0581 2008Primary Care Department, NHS North West London, London, England
| | - Adnan Kisa
- grid.457625.70000 0004 0383 3497School of Health Sciences, Kristiania University College, Oslo, Norway ,grid.265219.b0000 0001 2217 8588Department of Global Community Health and Behavioral Sciences, Tulane University, New Orleans, LA USA
| | - Sezer Kisa
- grid.412414.60000 0000 9151 4445Department of Nursing and Health Promotion, Oslo Metropolitan University, Oslo, Norway
| | - Ai Koyanagi
- Biomedical Research Networking Center for Mental Health Network (CiberSAM), San Juan de Dios Sanitary Park, Sant Boi de Llobregat, Spain ,grid.425902.80000 0000 9601 989XCatalan Institution for Research and Advanced Studies (ICREA), Barcelona, Spain
| | - Manasi Kumar
- grid.10604.330000 0001 2019 0495Department of Psychiatry, University of Nairobi, Nairobi, Kenya ,grid.83440.3b0000000121901201Division of Psychology and Language Sciences, University College London, London, UK
| | - Om P. Kurmi
- grid.25073.330000 0004 1936 8227Division of Respirology, Department of Medicine, McMaster University, Hamilton, Canada ,grid.8096.70000000106754565Faculty of Health and Life Sciences, Coventry University, Coventry, UK
| | - Carlo La-Vecchia
- grid.4708.b0000 0004 1757 2822Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy
| | - Demetris Lamnisos
- grid.440838.30000 0001 0642 7601Department of Health Sciences, School of Sciences, European University Cyprus, Nicosia, Cyprus
| | - Savita Lasrado
- grid.414767.70000 0004 1765 9143Department of Otorhinolaryngology, Father Muller Medical College, Mangalore, India
| | - Paolo Lauriola
- grid.5326.20000 0001 1940 4177Institute of Clinical Physiology, National Research Council, Pisa, Italy
| | - Shai Linn
- grid.18098.380000 0004 1937 0562School of Public Health, University of Haifa, Haifa, Israel
| | - Joana A. Loureiro
- grid.5808.50000 0001 1503 7226Laboratory for Process Engineering, Environment, Biotechnology and Energy (LEPABE), University of Porto, Porto, Portugal
| | - Raimundas Lunevicius
- grid.10025.360000 0004 1936 8470Department of General Surgery, School of Medicine, Liverpool University Hospitals NHS Foundation Trust, University of Liverpool, Liverpool, UK
| | - Aurea Madureira-Carvalho
- Institute of Research and Advanced, Training in Health Sciences and Technologies (INFACTS), Gandra, Portugal ,grid.5808.50000 0001 1503 7226Laboratório de Farmacognosia, Departamento de Química, Faculdade de Farmácia, Universidade Do Porto, Porto, Portugal
| | - Enkeleint A. Mechili
- grid.8127.c0000 0004 0576 3437Clinic of Social and Family Medicine, School of Medicine, University of Crete, Crete, Greece ,Department of Healthcare, Faculty of Public Health, University of Vlora, Vlora, Albania
| | - Azeem Majeed
- grid.7445.20000 0001 2113 8111Department of Primary Care and Public Health, Imperial College London, London, UK
| | - Ritesh G. Menezes
- grid.411975.f0000 0004 0607 035XForensic Medicine Division, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia
| | - Alexios-Fotios A. Mentis
- grid.418497.7Public Health Laboratories, Hellenic Pasteur Institute, Athens, Greece ,grid.411299.6Department of Neurology, University Hospital of Larissa, University of Thessaly, Larissa, Greece
| | - Atte Meretoja
- grid.1008.90000 0001 2179 088XSchool of Health Sciences, University of Melbourne, Melbourne, VIC Australia ,grid.15485.3d0000 0000 9950 5666Neurology Unit, Helsinki University Hospital, Helsinki, Finland
| | - Tomislav Mestrovic
- Clinical Microbiology and Parasitology Unit, Dr Zora Profozic Polyclinic, Zagreb, Croatia ,grid.502995.20000 0004 4651 2415University Centre Varazdin, University North, Varazdin, Croatia
| | - Tomasz Miazgowski
- grid.107950.a0000 0001 1411 4349Department of Propedeutics of Internal Diseases & Arterial Hypertension, Pomeranian Medical University, Szczecin, Poland
| | - Bartosz Miazgowski
- grid.107950.a0000 0001 1411 4349Center for Innovation in Medical Education, Pomeranian Medical University, Szczecin, Poland
| | - Andreea Mirica
- grid.432032.40000 0004 0416 9364Department of Statistics and Econometrics, Bucharest University of Economic Studies, Bucharest, Romania
| | - Mariam Molokhia
- grid.13097.3c0000 0001 2322 6764Faculty of Life Sciences and Medicine, King’s College London, London, UK
| | - Shafiu Mohammed
- grid.7700.00000 0001 2190 4373Heidelberg Institute of Global Health (HIGH), Heidelberg University, Heidelberg, Germany ,grid.411225.10000 0004 1937 1493Health Systems and Policy Research Unit, Ahmadu Bello University, Zaria, Nigeria
| | - Lorenzo Monasta
- Clinical Epidemiology and Public Health Research Unit, Burlo Garofolo Institute for Maternal and Child Health, Trieste, Italy
| | - Francesk Mulita
- grid.412458.eDepartment of General Surgery, University General Hospital of Patras, Patras, Greece
| | - Mukhammad David Naimzada
- grid.18763.3b0000000092721542Laboratory of Public Health Indicators Analysis and Health Digitalization, Moscow Institute of Physics and Technology, Dolgoprudny, Russia ,grid.411191.d0000 0000 9146 0440Experimental Surgery and Oncology Laboratory, Kursk State Medical University, Kursk, Russia
| | - Ionut Negoi
- grid.8194.40000 0000 9828 7548Department of General Surgery, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania ,Department of General Surgery, Emergency Hospital of Bucharest, Bucharest, Romania
| | - Subas Neupane
- grid.502801.e0000 0001 2314 6254Faculty of Social Sciences, Unit of Health Sciences, Tampere University, Tampere, Finland ,grid.502801.e0000 0001 2314 6254Gerontology Research Center, Tampere University, Tampere, Finland
| | - Bogdan Oancea
- grid.5100.40000 0001 2322 497XAdministrative and Economic Sciences Department, University of Bucharest, Bucharest, Romania
| | - Hans Orru
- grid.10939.320000 0001 0943 7661Institute of Family Medicine and Public Health, University of Tartu, Tartu, Estonia ,grid.12650.300000 0001 1034 3451Department of Public Health and Clinical Medicine, Sustainable Health, Umea University, Umea, Sweden
| | - Adrian Otoiu
- grid.432032.40000 0004 0416 9364Department of Statistics and Econometrics, Bucharest University of Economic Studies, Bucharest, Romania
| | - Nikita Otstavnov
- grid.18763.3b0000000092721542Laboratory of Public Health Indicators Analysis and Health Digitalization, Moscow Institute of Physics and Technology, Dolgoprudny, Russia
| | - Stanislav S. Otstavnov
- grid.18763.3b0000000092721542Laboratory of Public Health Indicators Analysis and Health Digitalization, Moscow Institute of Physics and Technology, Dolgoprudny, Russia ,grid.410682.90000 0004 0578 2005Department of Project Management, National Research University Higher School of Economics, Moscow, Russia
| | - Alicia Padron-Monedero
- grid.512889.f0000 0004 1768 0241National School of Public Health, Institute of Health Carlos III, Madrid, Spain
| | - Songhomitra Panda-Jonas
- grid.7700.00000 0001 2190 4373Department of Ophthalmology, Heidelberg University, Mannheim, Germany
| | - Shahina Pardhan
- grid.5115.00000 0001 2299 5510Vision and Eye Research Institute, Anglia Ruskin University, Cambridge, UK
| | - Jay Patel
- grid.9909.90000 0004 1936 8403Faculty of Medicine and Health, University of Leeds, Leeds, UK
| | - Paolo Pedersini
- grid.418563.d0000 0001 1090 9021IRCCS Fondazione Don Carlo Gnocchi, Milan, Italy
| | - Marina Pinheiro
- grid.5808.50000 0001 1503 7226Department of Chemistry, University of Porto, Porto, Portugal
| | - Ivo Rakovac
- World Health Organization (WHO) European Office for the Prevention and Control of Noncommunicable Diseases, Division of Country Health Programmes, WHO Regional Office for Europe, Moscow, Russian Federation
| | - Chythra R. Rao
- Department of Community Medicine, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, Karnataka India
| | - Salman Rawaf
- grid.7445.20000 0001 2113 8111Department of Primary Care and Public Health, Imperial College London, London, UK ,grid.271308.f0000 0004 5909 016XAcademic Public Health Department, Public Health England, London, UK
| | - David Laith Rawaf
- grid.7445.20000 0001 2113 8111World Health Organization (WHO) Collaborating Centre for Public Health Education and Training, Imperial College London, London, UK ,grid.439749.40000 0004 0612 2754University College London Hospitals, London, UK
| | | | - Luca Ronfani
- Clinical Epidemiology and Public Health Research Unit, Burlo Garofolo Institute for Maternal and Child Health, Trieste, Italy
| | - Dominic Sagoe
- grid.7914.b0000 0004 1936 7443Department of Psychosocial Science, University of Bergen, Bergen, Norway
| | - Francesco Sanmarchi
- grid.6292.f0000 0004 1757 1758Department of Biomedical and Neuromotor Sciences, Alma Mater Studiorum, University of Bologna, Bologna, Italy
| | - Milena M. Santric-Milicevic
- grid.7149.b0000 0001 2166 9385Faculty of Medicine, University of Belgrade, Belgrade, Serbia ,grid.7149.b0000 0001 2166 9385School of Public Health and Health Management, University of Belgrade, Belgrade, Serbia
| | - Brijesh Sathian
- grid.413548.f0000 0004 0571 546XGeriatrics and Long Term Care Department, Hamad Medical Corporation, Doha, Qatar ,grid.17236.310000 0001 0728 4630Faculty of Health & Social Sciences, Bournemouth University, Bournemouth, UK
| | - Aziz Sheikh
- grid.4305.20000 0004 1936 7988Centre for Medical Informatics, University of Edinburgh, Edinburgh, UK ,grid.38142.3c000000041936754XDivision of General Internal Medicine, Harvard University, Boston, MA USA
| | - Rahman Shiri
- grid.6975.d0000 0004 0410 5926Finnish Institute of Occupational Health, Helsinki, Finland
| | - Siddharudha Shivalli
- grid.8991.90000 0004 0425 469XDepartment of Medical Statistics, London School of Hygiene & Tropical Medicine, London, UK
| | - Inga Dora Sigfusdottir
- grid.9580.40000 0004 0643 5232Department of Psychology, Reykjavik University, Reykjavik, Iceland ,Icelandic Centre for Social Research and Analysis (ICSRA), Reykjavik, Iceland ,grid.21729.3f0000000419368729Department of Health and Behavior Studies, Teachers College, Columbia University, New York, NY USA
| | - Rannveig Sigurvinsdottir
- grid.9580.40000 0004 0643 5232Department of Psychology, Reykjavik University, Reykjavik, Iceland
| | | | | | - Catalin-Gabriel Smarandache
- grid.8194.40000 0000 9828 7548Department of General Surgery, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania
| | - Bogdan Socea
- grid.8194.40000 0000 9828 7548Department of General Surgery, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania
| | - Raúl A. R. C. Sousa
- Professional Association of Licensed Optometry Professionals, Linda-a-Velha, Portugal
| | - Paschalis Steiropoulos
- grid.12284.3d0000 0001 2170 8022Department of Respiratory Medicine, Medical School, Democritus University of Thrace, University General Hospital Dragana, Alexandroupolis, Greece
| | - Rafael Tabarés-Seisdedos
- grid.413448.e0000 0000 9314 1427Carlos III Health Institute, Biomedical Research Networking Center for Mental Health Network (CiberSAM), Madrid, Spain ,grid.5338.d0000 0001 2173 938XDepartment of Medicine, University of Valencia, Valencia, Spain
| | - Marcos Roberto Tovani-Palone
- grid.11899.380000 0004 1937 0722Department of Pathology and Legal Medicine, University of São Paulo, Ribeirão Preto, Brazil
| | - Fimka Tozija
- grid.7858.20000 0001 0708 5391Institute of Public Health of Republic of North Macedonia, Saints Cyril and Methodius University of Skopje, Skopje, North Macedonia
| | - Sarah Van de Velde
- grid.5284.b0000 0001 0790 3681Centre for Population, Family and Health, Department of Sociology, University of Antwerp, Antwerp, Belgium
| | | | - Massimiliano Veroux
- grid.8158.40000 0004 1757 1969Department of Medical, Surgical Sciences and Advanced Technologies, University of Catania, Catania, Italy
| | - Francesco S. Violante
- grid.6292.f0000 0004 1757 1758Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy ,grid.412311.4Occupational Health Unit, Sant’Orsola Malpighi Hospital, Bologna, Italy
| | - Vasiliy Vlassov
- grid.410682.90000 0004 0578 2005Department of Health Care Administration and Economics, National Research University Higher School of Economics, Moscow, Russia
| | - Yanzhong Wang
- grid.13097.3c0000 0001 2322 6764School of Population Health and Environmental Sciences, King’s College London, London, UK
| | - Ali Yadollahpour
- grid.11835.3e0000 0004 1936 9262Psychology Department, University of Sheffield, Sheffield, UK
| | - Sanni Yaya
- grid.28046.380000 0001 2182 2255School of International Development and Global Studies, University of Ottawa, Ottawa, ON Canada ,grid.4991.50000 0004 1936 8948The George Institute for Global Health, University of Oxford, Oxford, UK
| | - Mikhail Sergeevich Zastrozhin
- Laboratory of Genetics and Genomics, Moscow Research and Practical Centre On Addictions, Moscow, Russia ,grid.465497.dAddictology Department, Russian Medical Academy of Continuous Professional Education, Moscow, Russia
| | - Anasthasia Zastrozhina
- grid.465497.dPediatrics Department, Russian Medical Academy of Continuous Professional Education, Moscow, Russia
| | - Suzanne Polinder
- grid.5645.2000000040459992XDepartment of Public Health, Erasmus MC, University Medical Center, Rotterdam, The Netherlands
| | - Marek Majdan
- grid.412903.d0000 0001 1212 1596Department of Public Health, Institute for Global Health and Epidemiology, Faculty of Health Sciences and Social Work, Trnava University, Trnava, Slovakia
| |
Collapse
|
11
|
Charalampous P, Polinder S, Wothge J, von der Lippe E, Haagsma JA. A systematic literature review of disability weights measurement studies: evolution of methodological choices. Arch Public Health 2022; 80:91. [PMID: 35331325 PMCID: PMC8944058 DOI: 10.1186/s13690-022-00860-z] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/14/2021] [Accepted: 03/18/2022] [Indexed: 12/13/2022] Open
Abstract
Background The disability weight is an essential factor to estimate the healthy time that is lost due to living with a certain state of illness. A 2014 review showed a considerable variation in methods used to derive disability weights. Since then, several sets of disability weights have been developed. This systematic review aimed to provide an updated and comparative overview of the methodological design choices and surveying techniques that have been used in disability weights measurement studies and how they evolved over time. Methods A literature search was conducted in multiple international databases (early-1990 to mid-2021). Records were screened according to pre-defined eligibility criteria. The quality of the included disability weights measurement studies was assessed using the Checklist for Reporting Valuation Studies (CREATE) instrument. Studies were collated by characteristics and methodological design approaches. Data extraction was performed by one reviewer and discussed with a second. Results Forty-six unique disability weights measurement studies met our eligibility criteria. More than half (n = 27; 59%) of the identified studies assessed disability weights for multiple ill-health outcomes. Thirty studies (65%) described the health states using disease-specific descriptions or a combination of a disease-specific descriptions and generic-preference instruments. The percentage of studies obtaining health preferences from a population-based panel increased from 14% (2004–2011) to 32% (2012–2021). None of the disability weight studies published in the past 10 years used the annual profile approach. Most studies performed panel-meetings to obtain disability weights data. Conclusions Our review reveals that a methodological uniformity between national and GBD disability weights studies increased, especially from 2010 onwards. Over years, more studies used disease-specific health state descriptions in line with those of the GBD study, panel from general populations, and data from web-based surveys and/or household surveys. There is, however, a wide variation in valuation techniques that were used to derive disability weights at national-level and that persisted over time. Supplementary Information The online version contains supplementary material available at 10.1186/s13690-022-00860-z.
Collapse
Affiliation(s)
- Periklis Charalampous
- Department of Public Health, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
| | - Suzanne Polinder
- Department of Public Health, Erasmus MC University Medical Center, Rotterdam, The Netherlands
| | - Jördis Wothge
- German Environment Agency, Section Noise Abatement of Industrial Plants and Products, Noise Impact, Wörlitzer Pl. 1, 06844, Dessau-Roßlau, Germany
| | - Elena von der Lippe
- Department of Epidemiology and Health Monitorin, Robert Koch Institute, Berlin, Germany
| | - Juanita A Haagsma
- Department of Public Health, Erasmus MC University Medical Center, Rotterdam, The Netherlands
| |
Collapse
|
12
|
Motte J, Alvarenga RAF, Thybaut JW, Dewulf J. Quantification of the global and regional impacts of gas flaring on human health via spatial differentiation. Environ Pollut 2021; 291:118213. [PMID: 34563848 DOI: 10.1016/j.envpol.2021.118213] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/20/2021] [Revised: 08/26/2021] [Accepted: 09/19/2021] [Indexed: 06/13/2023]
Abstract
Globally, gas flaring caused 350 million tonnes of CO2 emissions in 2018. In addition to climate change, this burning practice also has other negative consequences for humans (e.g., respiratory problems) and the environment. The aim of this paper is to quantify the impact of flaring on human health (at the global and country level) via the calculation of the number of disability-adjusted life years (DALYs) caused by the combustion of associated gas. For this quantification, gas flaring emissions were linked with midpoint indicators (e.g., climate change) in life cycle assessment (LCA) for all selected countries. Regionalised characterisation factors (CFs) were applied in the impact assessment to allow for spatial differentiation. The global impact on human health caused by flaring was obtained by taking the sum for all countries. The results show that these flaring emissions globally cause 4.83 × 105 DALYs or 6.19 × 10-5 DALYs/person on an annual basis. This amounts to 0.12% of the total DALYs related to air pollution (from PM2.5) caused by all polluting sectors and 6.51% of the total DALYs related to climate change. To quantify these impacts, this study uses a country perspective rather than considering local characteristics. Thus, if more precise information at a more local level (e.g., city level) is sought, additional factors (e.g., meteorological conditions) should be taken into account. Finally, future research should also focus on the benefits of gas flaring reduction techniques to enable the selection of the most promising technologies for the elimination of gas flaring and its effects.
Collapse
Affiliation(s)
- Jordy Motte
- Research Group Sustainable Systems Engineering (STEN), Department of Green Chemistry and Technology, Ghent University, Coupure Links 653, 9000, Ghent, Belgium.
| | - Rodrigo A F Alvarenga
- Research Group Sustainable Systems Engineering (STEN), Department of Green Chemistry and Technology, Ghent University, Coupure Links 653, 9000, Ghent, Belgium
| | - Joris W Thybaut
- Laboratory for Chemical Technology (LCT), Department of Materials, Textiles and Chemical Engineering, Ghent University, Technologiepark 125, 9052, Ghent, Belgium
| | - Jo Dewulf
- Research Group Sustainable Systems Engineering (STEN), Department of Green Chemistry and Technology, Ghent University, Coupure Links 653, 9000, Ghent, Belgium
| |
Collapse
|
13
|
Lei SY, Zheng RS, Wei WW. [Progress on disability weights in the disease burden of cancer]. Zhonghua Zhong Liu Za Zhi 2021; 43:756-761. [PMID: 34289569 DOI: 10.3760/cma.j.cn112152-20200630-00611] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Cancer, one of the major public health problems in the world, threatens human health seriously, and the burden of disease is heavy. Disability adjusted life years (DALYs) have been increasingly used to estimate the burden of disease worldwide. Disability weights is a key ingredient for estimating DALYs, and its value directly affects the calculation of disease burden. In this review, we summarize the research methods, key issues, and progress on disability weights for cancer both domestic and abroad, in order to provide valuable information for the estimation of cancer disability weights in China.
Collapse
Affiliation(s)
- S Y Lei
- Office for Cancer Registry, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
| | - R S Zheng
- Office for Cancer Registry, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
| | - W W Wei
- Office for Cancer Registry, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
| |
Collapse
|
14
|
Li R, Cheng X, Schwebel DC, Yang Y, Ning P, Cheng P, Hu G. Disability-adjusted life years associated with population ageing in China, 1990-2017. BMC Geriatr 2021; 21:369. [PMID: 34134664 PMCID: PMC8207592 DOI: 10.1186/s12877-021-02322-7] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/18/2021] [Accepted: 06/01/2021] [Indexed: 01/15/2023] Open
Abstract
BACKGROUND The Chinese population has aged significantly in the last few decades. Comprehensive health losses including both fatal and non-fatal health outcomes associated with ageing in China have not been detailed. METHODS Based on freely accessible disability adjusted life years (DALYs) estimated by the Global Burden of Diseases (GBD) 2017, we adopted a robust decomposition method that ascribes changes in DALYs in any given country across two time points to changes resulting from three sources: population size, age structure, and age-specific DALYs rate per 100,000 population. Using the method, we calculated DALYs associated with population ageing in China from 1990 to 2017 and examined the counteraction between the effects of DALYs rate change and population ageing. This method extends previous work through attributing the change in DALYs to the three sources. RESULTS Population ageing was associated with 92.8 million DALYs between 1990 and 2017 in China, of which 65.8% (61.1 million) were years of life lost (YLLs). Males had comparatively more DALYs associated with population ageing than females in the study period. The five leading causes of DALYs associated with population ageing between 1990 and 2017 were stroke (23.6 million), chronic obstructive pulmonary disease (COPD) (18.3 million), ischemic heart disease (13.0 million), tracheal, bronchus, and lung cancer (6.1 million) and liver cancer (5.0 million). Between 1990 and 2017, changes in DALYs associated with age-specific DALY rate reductions far exceeded those related to population ageing (- 196.2 million versus 92.8 million); 57.5% (- 112.8 million) of DALYs were caused by decreases in rates attributed to 84 modifiable risk factors. CONCLUSION Population ageing was associated with growing health loss in China from 1990 to 2017. Despite the recent progress in alleviating health loss associated with population ageing, the government should encourage scientific research on effective and affordable prevention and control strategies and should consider investment in resources to implement strategies nationwide to address the future challenge of population ageing.
Collapse
Affiliation(s)
- Ruotong Li
- Department of Epidemiology and Health Statistics, Hunan Provincial Key Laboratory of Clinical Epidemiology, Xiangya School of Public Health, Central South University, Changsha, 410078, China
| | - Xunjie Cheng
- Department of Geriatric Medicine, Xiangya Hospital, Central South University, Changsha, China
| | - David C Schwebel
- Department of Psychology, University of Alabama at Birmingham, Birmingham, AL, USA
| | - Yang Yang
- Department of Biostatistics, College of Public Health and Health Professions, University of Florida, Gainesville, FL, USA.,Emerging Pathogens Institute, University of Florida, Gainesville, FL, USA
| | - Peishan Ning
- Department of Epidemiology and Health Statistics, Hunan Provincial Key Laboratory of Clinical Epidemiology, Xiangya School of Public Health, Central South University, Changsha, 410078, China
| | - Peixia Cheng
- Department of Epidemiology and Health Statistics, Hunan Provincial Key Laboratory of Clinical Epidemiology, Xiangya School of Public Health, Central South University, Changsha, 410078, China
| | - Guoqing Hu
- Department of Epidemiology and Health Statistics, Hunan Provincial Key Laboratory of Clinical Epidemiology, Xiangya School of Public Health, Central South University, Changsha, 410078, China. .,National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China.
| |
Collapse
|
15
|
Han L, Liu J, Yin P, Cai T, Zhou M. Burden of maternal disorders in China from 1990 to 2019: Analysis of the Global Burden of Disease Study 2019. Lancet Reg Health West Pac 2021; 11:100141. [PMID: 34327355 PMCID: PMC8315359 DOI: 10.1016/j.lanwpc.2021.100141] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 09/07/2020] [Revised: 03/10/2021] [Accepted: 03/18/2021] [Indexed: 11/25/2022]
Abstract
Background Efforts to quantify the burden of maternal disorders at the national and provincial levels are valuable for resource allocation and for development and adoption of public health policies. Methods Following the methods of the Global Burden of Diseases, Injuries, and Risk Factors Study 2019, the prevalence of maternal disorders and the resulting disability-adjusted life years (DALYs), years lived with disability(YLD), deaths, and years of life lost (YLL) at the national and provincial levels in China were examined for the 1990–2019 period. Estimated annual percentage changes (EAPCs) were calculated to estimate the trends of age-standardized rate (ASR) of prevalence, DALYs, death, and YLD due to maternal disorders and its main subcategories from 1990 to 2019. Findings In 2019, China had an estimated 0.85 million cases of maternal disorders (95% uncertainty interval: 0.65–1.08 million), with a 73% decline in absolute numbers from 1990 to 2019. The ASR of prevalence, DALYs and death for overall maternal disorders showed decreasing trends in China from 1990 to 2019 with the EAPCs being −3.25(95% confidence interval [CI] = −3.86 to −2.64), −8.07 (95% CI= −9.14 to −6.98), and −7.04 (95% CI= −7.99 to −6.07), respectively. The most pronounced decreases in trends in ASR of prevalence, DALYs and death were observed for maternal hemorrhage. Shandong, Hong Kong, Macao showed no significant trends in ASR of prevalence. Notably, the trends in ASR of prevalence due to maternal hypertensive disorders had been stable in China and most provinces. The trends in ASR of DALYs and death decreased the most in Jiangxi province. Interpretation The disease burden of prevalence, DALYs and death for overall maternal disorders decreased significantly in China from 1990 to 2019, however, the trends in ASR of prevalence due to maternal hypertensive disorders had been stable in China and most provinces. Funding The study is supported by grants from the Innovative Talent Support Plan of the Medical and Health Technology Project in Zhejiang Province (2021422878), Ningbo Science and Technology Project (202002N3152), Ningbo Health Branding Subject Fund (PPXK2018–02), Sanming Project of Medicine in Shen-zhen (SZSM201803080).
Collapse
Affiliation(s)
- Liyuan Han
- Hwa Mei Hospital, University of Chinese Academy of Sciences, Ningbo, Zhejiang, PR China.,Department of Global Health, Ningbo Institute of Life and Health Industry, University of Chinese Academy of Sciences, Ningbo, Zhejiang, PR China
| | - Jingjing Liu
- Department of Health Policy, Health Management College, Harbin Medical University, Harbin, Heilongjiang Province, PR China.,Department of Social Medicine, School of Public Health, Harbin Medical University, Harbin, Heilongjiang Province, PR China
| | - Peng Yin
- National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, 27# Nanwei Rd, Xicheng District, 100050 Beijing, PR China
| | - Ting Cai
- Hwa Mei Hospital, University of Chinese Academy of Sciences, Ningbo, Zhejiang, PR China.,Department of Global Health, Ningbo Institute of Life and Health Industry, University of Chinese Academy of Sciences, Ningbo, Zhejiang, PR China
| | - Maigeng Zhou
- National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, 27# Nanwei Rd, Xicheng District, 100050 Beijing, PR China
| |
Collapse
|
16
|
Gao Y, Wang X, Zeng Q. [Research progress of occupational disease assessment and application on burden of disease]. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 2020; 38:878-880. [PMID: 33287491 DOI: 10.3760/cma.j.cn121094-20190906-00370] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Burden of disease (BOD) refers to the pressure on the entire social economy and health caused by disease, disability and premature death, and the resulting economic and social impacts. It includes epidemiological burden and economic burden. BOD is widely used in the analysis and research of various chronic diseases, infectious diseases and cancers. With the rapid development of economy and industrialization, the health effects of occupational diseases on workers and the resulting disease burden have become a major public health and social problem, which has caused widespread concern. However, in the field of occupational disease burden research, domestic and foreign scholars have little research on it, and lack of systematic research and framework construction. Therefore, this paper is intended to summarize the occupational disease assessment and applied research of BOD, in order to provide data support for occupational disease monitoring, health promotion and optimal allocation of health resources, and to provide theoretical basis and reference basis for the reform of occupational health work and the formulation of health policies.
Collapse
Affiliation(s)
- Y Gao
- Tianjin Centers for Disease Control and Prevention, Tianjin 300011, China
| | - X Wang
- Tianjin Centers for Disease Control and Prevention, Tianjin 300011, China
| | - Q Zeng
- Tianjin Centers for Disease Control and Prevention, Tianjin 300011, China
| |
Collapse
|
17
|
Highfill T, Bernstein E. Using disability adjusted life years to value the treatment of thirty chronic conditions in the U.S. from 1987 to 2010: a proof of concept. Int J Health Econ Manag 2019; 19:449-466. [PMID: 30963361 DOI: 10.1007/s10754-019-09266-x] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/25/2018] [Accepted: 04/01/2019] [Indexed: 06/09/2023]
Abstract
Health care spending in the U.S. grew two trillion dollars from 1987 to 2010, a 400% increase, but our understanding of the value of that increase is limited. In this paper we estimate the net value of spending for thirty chronic diseases between 1987 and 2010 by assigning a monetary value to changes in health outcomes and relating it to the costs of treating each disease. Changes in health outcomes are measured using a newly-available time series of disability adjusted life years (DALYs) data from the Institute for Health Metrics and Evaluation. Spending on treatments are determined using health care expenditure data from nationally representative surveys. We find the net value of treatment has grown substantially for several diseases. Overall, 20 of the 30 chronic conditions studied experienced an increase in health outcomes over the period, with 8 of those 20 showing a decrease in per-patient spending. Our estimates of net value of health spending using DALYs data are simple to apply and results are generally consistent with previous estimates which usually involve onerous data collection methods to study a single disease. The DALYs data have potential to be a useful, low-cost way to measure changes in health outcomes. However, challenges remain in using DALYs data to accurately measure the changing value of health care spending on the treatment of disease.
Collapse
Affiliation(s)
- Tina Highfill
- Department of Commerce, US Bureau of Economic Analysis, 4600 Silver Hill Rd., Suitland, MD, 20746, USA.
| | - Elizabeth Bernstein
- Department of Commerce, US Bureau of Economic Analysis, 4600 Silver Hill Rd., Suitland, MD, 20746, USA
| |
Collapse
|
18
|
Walker C, Gibney ER, Mathers JC, Hellweg S. Comparing environmental and personal health impacts of individual food choices. Sci Total Environ 2019; 685:609-620. [PMID: 31195322 DOI: 10.1016/j.scitotenv.2019.05.404] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/18/2019] [Revised: 05/24/2019] [Accepted: 05/26/2019] [Indexed: 06/09/2023]
Abstract
Dietary choices affect personal health and environmental impacts, but little is known about the relation between these outcomes. Here we examine the intake-related health impacts and the food-production related impacts to ecosystems and human health by applying life cycle impact assessment methods to habitual diet data of 1457 European adults. We measured food production impacts for each individual in terms of Disability Adjusted Life Years (DALYs) as calculated by the Recipe 2016 life cycle impact assessment method using secondary production data, which were then compared with their personal health DALYs predicted from the known relationships between dietary choices and disease risk. Across this population cohort, each individual was estimated to lose on average 2.5 ± 0.9 DALYs per lifetime due to sub-optimal dietary intake (with seed and vegetable under-consumption the greatest contributors) and their food choices caused environmental human health impacts of 2.4 ± 1.3 DALYs (particularly due to the damage associated with production of meats, milk, and vegetables). Overall, there was no relationship between a healthier dietary pattern and the environmental human health impacts associated with production of its constituent foods (i.e. healthier diets did not have lower or higher production impacts). This was due to a combination of decreased meat consumption correlating with increased consumption of other foods, as well as the fact that under-consumption of some low impact foods yielded high personal health consequences. However, for specific food items synergies and tradeoffs could be identified. For example, reduced processed meat consumption benefits both personal and environmental health. Every DALY caused by higher whole grain and vegetable production and consumption would be offset by reduced disease risk that equated to an average of 7.7 (5.7 to 10.4) and 1.4 (0.9 to 2.5) lower personal health DALYs, respectively.
Collapse
Affiliation(s)
- Christie Walker
- Institute of Environmental Engineering, ETH Zurich, HPZ E33, John-von-Neumann-Weg 9, 8093 Zürich, Switzerland.
| | - Eileen R Gibney
- Institute of Food and Health, University College Dublin, Dublin 4, Ireland
| | - John C Mathers
- Human Nutrition Research Centre, Institute of Cellular Medicine, Newcastle University, Newcastle NE2 4HH, UK
| | - Stefanie Hellweg
- Institute of Environmental Engineering, ETH Zurich, HPZ E33, John-von-Neumann-Weg 9, 8093 Zürich, Switzerland
| |
Collapse
|
19
|
Rommel A, von der Lippe E, Plaß D, Wengler A, Anton A, Schmidt C, Schüssel K, Brückner G, Schröder H, Porst M, Leddin J, Tobollik M, Baumert J, Scheidt-Nave C, Ziese T. BURDEN 2020-Burden of disease in Germany at the national and regional level. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2018; 61:1159-66. [PMID: 30083946 DOI: 10.1007/s00103-018-2793-0] [Citation(s) in RCA: 20] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Abstract
BACKGROUND Evidence-based policy measures need non-interest-guided information about the health status of a population and the diseases that affect the population the most. In such cases, a national burden of disease study can provide reliable insights at the regional level. AIM This article presents the potential of the BURDEN 2020 project and its expected outcome for Germany at the national and regional level. METHODS The BURDEN 2020 project uses several indicators including years of life lost (YLL) to cover the impact of mortality and years lived with disability (YLD) to cover morbidity. The sum of both is the measure of population health called disability adjusted life years (DALY). RESULTS The study ranks individual diseases and risk factors based on their impact on population health. The burden of disease approach is assumed to be sensitive to subnational differences and may generate immediate benefits for regional planning. The BURDEN 2020 study will pilot a national burden of disease study for Germany that will later be transformed into a continuous data processing and visualization tool. This is done by using, modifying and supplementing the methodology employed by the Global Burden of Disease (GBD) study to better fit the needs of health policy in Germany. This study is aimed at calculating the disease burden for up to 17 preselected diseases. Furthermore, the estimates of burden of disease are attributed to a selected set of risk factors. CONCLUSION The Burden 2020 study will provide the results of a new, health-related data processing system to the public. This includes a noninterest-guided presentation of the burden of disease (DALY) in Germany at the national and regional level.
Collapse
|
20
|
Goel A, Ola D, Veetil AV. Burden of disease for workers attributable to exposure through inhalation of PPAHs in RSPM from cooking fumes. Environ Sci Pollut Res Int 2019; 26:8885-8894. [PMID: 30719671 DOI: 10.1007/s11356-019-04242-x] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/12/2018] [Accepted: 01/14/2019] [Indexed: 06/09/2023]
Abstract
Polycyclic aromatic hydrocarbons (PAHs), some of which are classified as possible carcinogens (WHO), have been detected in cooking fumes in considerable amounts. Distribution of 24 PAHs on varying particle sizes was analyzed in cooking emission. Analysis of cooking fumes from vegetarian and non-vegetarian food was carried out separately in the kitchen of a hostel mess in IIT Kanpur during November 2012 and February 2013. Respirable suspended particulate matter (RSPM) and particle-bound polycyclic aromatic hydrocarbons (PPAHs) showed a similar sequence regarding concentration observed in vegetarian and non-vegetarian food. PAHs with carcinogenic potential was detected and quantified mostly in the fine particles. Total PAH concentrations in the fine and ultrafine ranges together accounted for > 90% of the total carcinogenic PAHs, highlighting them as primary carriers of PAHs rather than coarser particles. Benzo [a] pyrene (B [a]P) levels contribute > 70% to total carcinogenic potential and > 60%, to mutagenic potential, respectively. The total toxicity impact on the workers due to the PAHs emitted from cooking fumes was 3.374 × 10-10 DALYs, with B [a] P contributing the most (> 70%) despite its low concentration. Exposure to cooking fumes especially for people involved in this activity on a daily basis (chefs, hostel mess workers, among others) raises health concerns. An extensive examination of impacts due to exposure to emissions in both particle and gas phase on a long-term basis is required.
Collapse
Affiliation(s)
- Anubha Goel
- Department of Civil Engineering, Indian Institute of Technology Kanpur, 208016, Kanpur, India.
- Atmospheric Particle Technology Lab (APTL) at Center for Environmental Science and Engineering (CESE), IIT Kanpur, 208016, Kanpur, India.
| | - Deepshikha Ola
- Department of Civil Engineering, Indian Institute of Technology Kanpur, 208016, Kanpur, India
| | - Anitha V Veetil
- Department of Civil Engineering, Indian Institute of Technology Kanpur, 208016, Kanpur, India
| |
Collapse
|
21
|
Halilu S, Iliyasu G, Hamza M, Chippaux JP, Kuznik A, Habib AG. Snakebite burden in Sub-Saharan Africa: estimates from 41 countries. Toxicon 2018; 159:1-4. [PMID: 30594637 DOI: 10.1016/j.toxicon.2018.12.002] [Citation(s) in RCA: 51] [Impact Index Per Article: 8.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/27/2018] [Accepted: 12/21/2018] [Indexed: 11/20/2022]
Abstract
There is no reliable estimate of burden of snakebite-envenoming (SBE) in Sub-Saharan Africa (SSA). We derived from a meta-analysis the burden of SBE related deaths, amputations and Post-Traumatic Stress Disorder (PTSD) in 41 countries in SSA. The annual burden was estimated at 1.03 million DALYs (95% Confidence Interval: 0.80-1.28 million DALYs). This is similar to or higher than the burden of many Neglected Tropical Diseases (NTDs) and the finding advocates for a commensurate resources allocation towards control of SBE.
Collapse
Affiliation(s)
- Sadiq Halilu
- Infectious & Tropical Diseases Unit, Aminu Kano Teaching Hospital, Bayero University, Kano, Nigeria
| | - Garba Iliyasu
- Infectious & Tropical Diseases Unit, Aminu Kano Teaching Hospital, Bayero University, Kano, Nigeria
| | - Muhammad Hamza
- Infectious & Tropical Diseases Unit, Aminu Kano Teaching Hospital, Bayero University, Kano, Nigeria
| | | | | | - Abdulrazaq G Habib
- Infectious & Tropical Diseases Unit, Aminu Kano Teaching Hospital, Bayero University, Kano, Nigeria.
| |
Collapse
|
22
|
Rahmani H, Sarabi Asiabar A, Niakan S, Hashemi SY, Faramarzi A, Manuchehri S, Rajabi Vasokolaei G. Burden of esophageal cancer in Iran during 1995-2015: Review of findings from the Global Burden of Disease studies. Med J Islam Repub Iran 2018; 32:55. [PMID: 30175081 DOI: 10.14196/mjiri.32.55] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/15/2018] [Indexed: 12/18/2022] Open
Abstract
Background: Iran is located in Asian esophageal cancer belt, with age-standardized incidence rate (ASR) of approximately 7 per 100,000 for both men and women. To provide potential solution recommendations for achieving accurate estimations regarding the burden of the disease in Iran, we designed a study to assess the burden of esophageal cancer in Iran during 1995-2015 by collecting data from the Global Burden of Disease studies.
Methods: Data were extracted from the Global Burden of Disease (GBD) during 1995-2015, which were published by the Institute for Health Metrics and Evaluation. For this purpose, disability adjusted life years (DALYs), incidence, and prevalence rate were applied to report burden of esophageal cancer based on gender and age group in Iran during 1995-2015. The Cochran-Armitage and t test were used to assess statistical significance. Stata Version 13 and Excel 2016 were used for data analysis.
Results: During 1995-2015, in total, 304 102 DALYs (179 562 for males vs. 124 540 for females) were attributed to esophageal cancer in Iran. In both genders and all ages, the number of DALYs increased significantly from 45 018 in 1995 to 74 399 in 2015.
Conclusion: Esophageal cancer is still a public health issue in Iran. Most of DALYs were due to years of life lost (YLL), suggesting the need for prevention, early detection, and screening programs. P-value was statistically significant just between male and female groups (p<0.05).
Collapse
|
23
|
Xu RB, Jin DY, Song Y, Wang XJ, Dong YH, Yang ZG, Chen YJ, Ma J. [Study on the disease burden of Chinese adolescent in 2015]. Zhonghua Yu Fang Yi Xue Za Zhi 2017; 51:910-914. [PMID: 29036993 DOI: 10.3760/cma.j.issn.0253-9624.2017.10.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/07/2023]
Abstract
Objective: To discuss the main causes and risk factors of disability and death among current Chinese adolescents. Methods: Subnational data of China from Global Burden of Disease Study 2015 (GBD 2015) was used to rank the causes and risk factors leading to death and disability adjusted life years (DALY) in Chinese adolescents aged between 10 and 19 years old, and thereby to analyze the main cauese and risk factors of death and DALY among Chinese adolescents in different genders. Results: In 2015, among Chinese adolescents aged 10-19 years old, the total DALY was 13 million 490 thousand years, and the total number of deaths was 63 258 cases. The top 3 causes of DALY were skin and subcutaneous diseases, iron-deficiency anemia and road injuries, resulting in DALY (constituent ratio) of 1 411 (10.5%), 1 094 (8.1%) and 1 029 (7.6%) thousand years respectively. The top 3 causes of death were road injuries, drowning and leukemia, causing 13 881 (21.9%), 9 895 (15.6%) and 4 620 (7.3%) deaths (constituent ratio) respectively. The top 3 risk factors of DALY were iron deficiency, alcohol use and drug use, causing 1 094 (8.1%), 487 (3.6%) and 220 thousand years (1.6%) DALY (constituent ratio) respectively. The top 3 risk factors of death were alcohol use, occupational injuries and drug use, causing 5 957 (9.4%), 1 523 (2.4%) and 810 (1.3%) deaths respectively. Conclusion: Unintentional injury was the top cause of DALY and death in Chinese adolescents, followed by skin and subcutaneous diseases and iron-deficiency anemia. Iron deficiency and alcohol use were the top two risk factors of DALY and death.
Collapse
Affiliation(s)
- R B Xu
- Peking University Health Science Centre. Institute of Child and Adolescent Health of Peking University, Beijing 100191, China
| | | | | | | | | | | | | | | |
Collapse
|
24
|
Ughasoro MD, Onwujekwe OE, Ojinnaka NC. Determining the disability adjusted life years lost to childhood and adolescence epilepsy in southeast Nigeria: An exploratory study. Epilepsy Res 2016; 125:37-41. [PMID: 27389705 DOI: 10.1016/j.eplepsyres.2016.05.006] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/12/2016] [Revised: 04/16/2016] [Accepted: 05/17/2016] [Indexed: 10/21/2022]
Abstract
OBJECTIVES Disease burden has always been based on associated mortality. An accurate measurement of the burden of epilepsy should rely on both morbidity and mortality. This will close any existing gap in knowledge and provide useful information to aid evidence-based decision-making. In this study, burden of epilepsy was estimated, using disability-adjusted-life-years (DALYs), using disability weights for epilepsy that were part of the Global Burden of Disease 2010 work. METHODS The study was conducted at the University of Nigeria Teaching Hospital, Enugu. Interviewer-administered questionnaire was used to collect information from patients with epilepsy who presented to neurology clinic. The prevalence of epilepsy, and case-fatality were obtained from previous publications. The DALYs were estimated by adding together the years lost to disability (YLDs) and years lost to life (YLLs) to epilepsy (DALYs=YLD+YLL). DALYs were dis-aggregated by age group and by whether or not epilepsy was treated. RESULTS A total of 134 children with epilepsy-interviews were conducted. Some 56% and 44% of the subjects had primary and secondary epilepsy, respectively. The childhood epilepsy caused 1.63 YLLs per 1000 population, 0.45 YLDs per 1000 population and 2.08 DALY per 1000 population. The highest burden was in children within the age group of 5-14 years at 2.18 DALY per 1000 people. The YLDs was higher (0.63/1000 population) among the untreated group, compared with the YLDs (0.27/1000 population) among the treated group. The YLLs lost for children with secondary epilepsy (2.23/1000 population) was higher than primary epilepsy YLLs of 1.07/1000 population. SIGNIFICANCE The DALYs due to childhood epilepsy was high. The YLDs was high among children with epilepsy who were not on treatment. The YLLs were found to be the same in all children with epilepsy, irrespective of their treatment status. This imperatively necessitates the de-emphasis on just mortality as an indicator of the burden of childhood epilepsy but rather a holistic approach should be adopted in considering both the mortality and disability in monitoring the outcome of health interventions.
Collapse
Affiliation(s)
- Maduka D Ughasoro
- Department of Paediatrics, University of Nigeria, Enugu Campus, Enugu, Nigeria.
| | - Obinna E Onwujekwe
- Department of Pharmacology and Therapeutics, and Department of Health Administration and Management, University of Nigeria, Enugu Campus, Enugu, Nigeria
| | - Ngozi C Ojinnaka
- Department of Paediatrics, University of Nigeria, Enugu Campus, Enugu, Nigeria
| |
Collapse
|
25
|
Oldenkamp R, van Zelm R, Huijbregts MAJ. Valuing the human health damage caused by the fraud of Volkswagen. Environ Pollut 2016; 212:121-127. [PMID: 26840525 DOI: 10.1016/j.envpol.2016.01.053] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/26/2015] [Revised: 01/19/2016] [Accepted: 01/19/2016] [Indexed: 06/05/2023]
Abstract
Recently it became known that Volkswagen Group has been cheating with emission tests for diesel engines over the last six years, resulting in on-road emissions vastly exceeding legal standards for nitrogen oxides in Europe and the United States. Here, we provide an estimate of the public health consequences caused by this fraud. From 2009 to 2015, approximately nine million fraudulent Volkswagen cars, as sold in Europe and the US, emitted a cumulative amount of 526 ktonnes of nitrogen oxides more than was legally allowed. These fraudulent emissions are associated with 45 thousand disability-adjusted life years (DALYs) and a value of life lost of at least 39 billion US dollars, which is approximately 5.3 times larger than the 7.3 billion US dollars that Volkswagen Group has set aside to cover worldwide costs related to the diesel emissions scandal.
Collapse
Affiliation(s)
- Rik Oldenkamp
- Department of Environmental Science, Institute for Wetland and Water Research, Radboud University, P.O. Box 9010, 6500 GL Nijmegen, The Netherlands.
| | - Rosalie van Zelm
- Department of Environmental Science, Institute for Wetland and Water Research, Radboud University, P.O. Box 9010, 6500 GL Nijmegen, The Netherlands
| | - Mark A J Huijbregts
- Department of Environmental Science, Institute for Wetland and Water Research, Radboud University, P.O. Box 9010, 6500 GL Nijmegen, The Netherlands
| |
Collapse
|
26
|
Haagsma JA, Maertens de Noordhout C, Polinder S, Vos T, Havelaar AH, Cassini A, Devleesschauwer B, Kretzschmar ME, Speybroeck N, Salomon JA. Assessing disability weights based on the responses of 30,660 people from four European countries. Popul Health Metr 2015; 13:10. [PMID: 26778920 PMCID: PMC4715333 DOI: 10.1186/s12963-015-0042-4] [Citation(s) in RCA: 113] [Impact Index Per Article: 12.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/08/2014] [Accepted: 03/17/2015] [Indexed: 11/25/2022] Open
Abstract
BACKGROUND In calculations of burden of disease using disability-adjusted life years, disability weights are needed to quantify health losses relating to non-fatal outcomes, expressed as years lived with disability. In 2012 a new set of global disability weights was published for the Global Burden of Disease 2010 (GBD 2010) study. That study suggested that comparative assessments of different health outcomes are broadly similar across settings, but the significance of this conclusion has been debated. The aim of the present study was to estimate disability weights for Europe for a set of 255 health states, including 43 new health states, by replicating the GBD 2010 Disability Weights Measurement study among representative population samples from four European countries. METHODS For the assessment of disability weights for Europe we applied the GBD 2010 disability weights measurement approach in web-based sample surveys in Hungary, Italy, Netherlands, and Sweden. The survey included paired comparisons (PC) and population health equivalence questions (PHE) formulated as discrete choices. Probit regression analysis was used to estimate cardinal values from PC responses. To locate results onto the 0-to-1 disability weight scale, we assessed the feasibility of using the GBD 2010 scaling approach based on PHE questions, as well as an alternative approach using non-parametric regression. RESULTS In total, 30,660 respondents participated in the survey. Comparison of the probit regression results from the PC responses for each country indicated high linear correlations between countries. The PHE data had high levels of measurement error in these general population samples, which compromises the ability to infer ratio-scaled values from discrete choice responses. Using the non-parametric regression approach as an alternative rescaling procedure, the set of disability weights were bounded by distance vision mild impairment and anemia with the lowest weight (0.004) and severe multiple sclerosis with the highest weight (0.677). CONCLUSIONS PC assessments of health outcomes in this study resulted in estimates that were highly correlated across four European countries. Assessment of the feasibility of rescaling based on a discrete choice formulation of the PHE question indicated that this approach may not be suitable for use in a web-based survey of the general population.
Collapse
Affiliation(s)
- Juanita A Haagsma
- />Department of Public Health, Erasmus MC, P.O. Box 2040, , 3000, CA Rotterdam, The Netherlands
- />Institute for Health Metrics and Evaluation, University of Washington, Seattle, USA
| | | | - Suzanne Polinder
- />Department of Public Health, Erasmus MC, P.O. Box 2040, , 3000, CA Rotterdam, The Netherlands
| | - Theo Vos
- />Institute for Health Metrics and Evaluation, University of Washington, Seattle, USA
| | - Arie H Havelaar
- />National Institute for Public Health and the Environment, Centre for Infectious Disease Control, Bilthoven, the Netherlands
- />Emerging Pathogens Institute, University of Florida, Gainesville, Florida USA
- />Institute for Risk Assessment Sciences, Utrecht University, Utrecht, the Netherlands
| | | | - Brecht Devleesschauwer
- />Department of Virology, Parasitology and Immunology, Faculty of Veterinary Medicine, Ghent University, Merelbeke, Belgium
| | - Mirjam E Kretzschmar
- />National Institute for Public Health and the Environment, Centre for Infectious Disease Control, Bilthoven, the Netherlands
- />Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands
| | - Niko Speybroeck
- />Institute of Health and Society (IRSS), Université catholique de Louvain, Leuven, Belgium
| | - Joshua A Salomon
- />Department of Global Health and Population, Harvard School of Public Health, Boston, USA
| |
Collapse
|
27
|
Haagsma JA, Polinder S, Cassini A, Colzani E, Havelaar AH. Review of disability weight studies: comparison of methodological choices and values. Popul Health Metr 2014; 12:20. [PMID: 26019690 PMCID: PMC4445691 DOI: 10.1186/s12963-014-0020-2] [Citation(s) in RCA: 48] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/12/2013] [Accepted: 07/20/2014] [Indexed: 10/29/2022] Open
Abstract
INTRODUCTION The disability-adjusted life year (DALY) is widely used to assess the burden of different health problems and risk factors. The disability weight, a value anchored between 0 (perfect health) and 1 (equivalent to death), is necessary to estimate the disability component (years lived with disability, YLDs) of the DALY. After publication of the ground-breaking Global Burden of Disease (GBD) 1996, alternative sets of disability weights have been developed over the past 16 years, each using different approaches with regards to the panel, health state description, and valuation methods. The objective of this study was to review all studies that developed disability weights and to critically assess the methodological design choices (health state and time description, panel composition, and valuation method). Furthermore, disability weights of eight specific conditions were compared. METHODS Disability weights studies (1990¿2012) in international peer-reviewed journals and grey literature were identified with main inclusion criteria being that the study assessed DALY disability weights for several conditions or a specific group of illnesses. Studies were collated by design and methods and evaluation of results. RESULTS Twenty-two studies met the inclusion criteria of our review. There is considerable variation in methods used to derive disability weights, although most studies used a disease-specific description of the health state, a panel that consisted of medical experts, and nonpreference-based valuation method to assess the values for the majority of the disability weights. Comparisons of disability weights across 15 specific disease and injury groups showed that the subdivision of a disease into separate health states (stages) differed markedly across studies. Additionally, weights for similar health states differed, particularly in the case of mild diseases, for which the disability weight differed by a factor of two or more. CONCLUSIONS In terms of comparability of the resulting YLDs, the global use of the same set of disability weights has advantages, though practical constraints and intercultural differences should be taken into account into such a set.
Collapse
Affiliation(s)
- Juanita A Haagsma
- Department of Public Health, Erasmus Medical Center, Rotterdam, 3000 CA, The Netherlands
| | - Suzanne Polinder
- Department of Public Health, Erasmus Medical Center, Rotterdam, 3000 CA, The Netherlands
| | - Alessandro Cassini
- Office of the Chief Scientist, European Centre for Disease Prevention and Control, Stockholm, SE-171 83, Sweden
| | - Edoardo Colzani
- Office of the Chief Scientist, European Centre for Disease Prevention and Control, Stockholm, SE-171 83, Sweden
| | - Arie H Havelaar
- National Institute for Public Health and the Environment, Laboratory for Zoonoses and Environmental Microbiology, Bilthoven, 3720 BA, The Netherlands ; Utrecht University, Institute for Risk Assessment Sciences, Utrecht, 3508 TD, the Netherlands
| |
Collapse
|